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INTRODUCTION 
The siddha system of medicine is regaining its lost glory throughout the world 
today.  The world Health organization (WHO) defines health a “State of complete 
physical, mental and social well being and not merely the absence of disease”.  This 
doctrine was already proclaimed even before the prehistoric period by the unique 
system of siddha medicine. 
 Thus this is the first system to emphasize health as a perfect state of physical, 
psychological, social and spiritual component of a humen being.  This explanation is 
quoted in “Thirumanthiram” which is a pioneer worked by Thirumoolar as follows 
 lXh<hKmz<!Ofib<!lVf<oke!ziGl<!
lxh<hKt!Ofib<!lVf<okes<!siZl<!
lXh<h!kqeqOfib<!uivikqVg<g!
lXh<hK!siju!lVf<okeziOl!
. kqVlf<kqvl<< << << <!
!
One that cures physical ailment is medicine 
One that cures psychological ailment is medicine 
One that prevents ailment is medicine 
One that bestows immortality is medicine 
 Agathiyar classified the disease into 4448 types.  The disease of nasal origin is 
classified into 86 types and one among them is ‘peenisam’ and ‘KABHA 
PEENISAM’ is one of the classifications in peenisanoi. 
 The signs and symptoms of KABHA PEENISAM are mentioned as headache, 
excessive lacrimation, nasal congestion, rhinorrhoea, cough with expectoration can be 
similarly correlated as modern medicine is ‘sinusitis’. 
 Sinusitis affects a tremendous proportion of the populaiton, accounts for 
millions of visits to primary care physician each year. 
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 According to National ambulatory medical care survey (NAMCS) data, 
sinusitis is the fifth leading disease. 
 The prevalence of sinusitis estimated to be 14% of the global population and it 
is higher in women compared to men (57% Vs 3.4%).  Approximately 0.5% to 2% of 
adults and 6% to 13% of children are complicated by bacterial sinusitis. 
 So I chose PERUNJCHIRAKA CHOORANAM inscribed in the text of 
gunapadam mooligai vaguppu, part I for the treatment of “KABHA PEENISAM”. 
 The trial drugs has been chosen for the clinical study because of the easy 
availability of the ingredients and of the convenience in the preparation of medicine. 
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AIM AND OBJECTIVES 
Aim 
 The recent pervasiveness rate of “Sinusitis” in our country is very high due to 
environment factor.   Now-a-days, it builds up as a major health concern and need of 
great focus on its efficacious treatment with  better quality of life style.  Perhaps the 
available studies are insufficient in siddha system compared with modern trend 
settings, impresses the author to work a telescopic sight on this topic. 
 To study the efficacy of the trail drug PERUNJCHIRAKA CHOORANAM 
(internal) in the treatment of KABHA PEENISAM (Sinusitis). 
Objectives 
Primary objective 
 To evaluate the clinical eficacy of the drug Perunjchiraka chooranam (internal) 
in the treatment of Kabha peenisam (sinusitis). 
Secondary objective 
 To explore the exact definition, etiology, clinical features, diagnosis, 
prognosis and investigations for kabha peenisam in siddha literatures and 
correlation with modern science. 
 To survey the incidence of the disease, according to age, occupation, socio 
economic status, habits, paruva kaalangal and thinai. 
 To divulge how the mukkutram and seven udarkattugal are deranged in this 
disease. 
 To document changes in the envagai thervugal of the disease. 
 To perceive the adverse effects of the trail drug. 
 To evaluate the biochemical, pharmacological, acute toxicity and 
microbiological studies of the trial drug. 
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ABSTRACT 
 
 As estimated 134 million Indians suffer from sinusitis both acute and chronic.  
On an average about one in eight Indians suffer from sinusitis.  The incidence in the 
increase of infectious diseases in recent times is due to changes in environment, 
exposure to pollution factors, abnormal dietary habits and life style. 
 Twenty patients of both sexes were selected as In-patients and another twenty 
patients as Out-patients in PG Pothu Maruthuvam department, Government Siddha 
Medical College and hospital, Palayamkottai.  The selected patients were 
administered with the trial medicine till the period of study. 
 PERUNJCHIRAKA CHOORANAM – 2gm was given twice a day, after 
meal.   
 The trial medicine was subjected to Biochemical, pharmacological, anti 
microbial and acute toxicity study. 
 At end of this trial study, majority of  cases showed good results. 
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SIDDHA ASPECT 
 
 Siddars classified the diseases into 4448 types.  Among them the 
diseases of nasal origin are 86, one such disease is peenisam and 
KABHAPEENISAM is one among 9 types of peenisa noi. 
 The specific signs and symptoms of the topic kapha Peenisam other 
information regarding definition, aetiology, general signs and symptoms, 
pathology and naadi nadai of Peenisam have been dealt with, since they are 
common for all types of Peenisam. 
SYNONYMS: 
• &g<gjmh<H!
• fQIg<Ogiju!
• &g<G!fQIhib<kz<!
DEFINITION 
SIDDHA MARUTHUVAM 
 &g<gqe<! Kjtg<Gt<! squf<K?! Kl<lz<?! g{<! squf<K! fQIuckz<?!
kjzOfib<?! ncg<gc! &g<jg! sqf<kq! stq?! sQp<?! GVkq! outqbikz<! Ngqb!
-bz<Hjmb!OfibiGl</!
AETIOLOGY 
1. SIDDHA MARUTHUVAM, ARUVAI MARUTHUVAM, NOI NADAL 
NOI MUDHAL NADAL Part (2): 
 In the above literatures, the etiology of peenisam is as follows, 
• lqGf<k!Gtqi<f<k!fQjv!hVgz<!)Cold water drinking) 
• heq!)n*!Gtqi<f<k!gix<xqzQMhmz<!)Cold air exposure) 
6 
 
• Hjg!)n*!HPkq!hcf<Kt<t!gix<jx!Suisqk<kz<!)Air pollution) 
• wkqi<!gix<xqz<!osz<zz< 
• Kl<ljzB{<M!h{<[l<!ohiVt<gjt!Lgi<kz<!)Allergens) 
• dmz<!ouh<hljmf<kqVg<Gl<!OhiK!Jbk<jk!ohVg<g!%cb!Gtqi<f<k!
fQjv!kjzLPgz< 
• Gtqi<s<sqbie!ohiVt<gjt!dm<ogit<tz< 
• g{<{QI?!uif<kq!kMk<kz< 
• nkqgl<!dvk<K!Ohsz<!)Loud speech) 
• ntUg<G!lqGf<K?!Gjxf<K!fqk<kqjv!ogit<tz<!)Distrubed sleep) 
• Olg!Ofib<g<G!Kj{bigUl<!uVl</!)Syphlis) 
 
2. AGASTHIYAR KANMA KAANDAM 300: 
 hgVOue<!l{<jmbqz<!gvh<hie<!gm<Ml<< < < < < < << < < < < < << < < < < < <!
! ! hgviqb!hQeqsr<g!tqv{k<!OkiMQ < <Q < <Q < < !
! fqgiqz<zi!ouiV!kjzOfib<!l{<jmg<Gk<Kl<< < < < < << < < < < << < < < < <!
! ! fqslig!uf<kge<ll<!fqslib<g<!OgT< < < < << < < < << < < < < !
! kgvOu!gibck<k!zqjz!hxqk<kz<< < << < << < <!
! ! ktqi<ogiPf<K!kjpLxqk<kz<!hm<jmoum<mz<< < < < < < << < < < < < << < < < < < <!
! fqgiqz<zi!H,h<hxqk<kz<!Oui<ogicgt< < < < << < < < << < < < < <!oum<mz<< < << < << < <!
! ! fqjeUogm<M!squosf<K!kjebck<kziOl< < << < << < < !
! According to Agasthiyar kanmakandam 300, Peenisam is considered to 
be a kanma disease.  The activities like plucking leaves, fruits, young shoots, 
flowers, cutting barks, roots, twigs and hurting animals will cause Peenisam. 
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3. SIDDHA MARUTHUVANGA CHURUKKAM 
 “uqpqbqeqz<!fQvmg<gqz<!uqkliebqVf<K!Ovigl<< Q < < < << Q < < < << Q < < < <!
! upqhM!hQeqsr<gt<!uf<kqMl<!Ofk<v!Ovigl<Q < < < < < <Q < < < < < <Q < < < < < <!
! nPgqMl<!sqvsqz<!Ovigl<< < << < << < <”!
  Due to the control of lacrimation it will causes peenisam, disease of eye 
and head. 
4. JEEVA RATCHAMIRTHAM (NASIGA ROGA PETHAM) 
 The literature describes the below etiological features. 
• Exposure to cold air 
• Nasal blockage by dust 
• Loud speech 
• Excess sleep or sleeplessness 
• Taking bath in cold water daily 
• Controlling the urge, tears and vomiting 
• Sleeping in uneven bed 
• Excessive sexual indulgence 
All these activities vitiate Vadham, Pitham and kabham which affects 
the nose and cause Peenisam. 
5.PATHINENN SIDDHAR NAADI SASTHIRAM AND GURU NAADI 
 hqfQsf<kie<!uvziX!osiz<zg<!Og{<lqe<Q < < < < < <Q < < < < < <Q < < < < < <!
! ! OskLme<!geozPl<H!uib<U!< < << < << < < Osi<k<K< << << < !
! DXVkq!l{<jmbqOz!okiGg<gh<hm<M< < < << < < << < < < !
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! ! dXkqBme<!uiBgr<Og!BXk<Khqe<El<< < < < << < < < << < < < <!
! =eLme<!OeiMl<!fQIsQ!pqvk<kl<< < Q Q < << < Q Q < << < Q Q < <!
! ! hqck<K!gVr<giK!&g<gqOeiM< < << < << < < !
! OkeVuq!uf<kE!Ohiz<!osr<g{<!sQVBI< < < < Q< < < < Q< < < < Q !
! ! Osi<f<K!uQPl<!hQeqsk<kqe<!osb<jgbiOl/< < Q < Q < < << < Q < Q < < << < Q < Q < < < !
  The heat and vayu combine together and affect the head, thereby 
causing Peenisam. 
 
6. T.V. SAMBASIVAM PILLAI MARUTHUVA AGARATHI 
• Mucus discharge through the nostrils is due to an inflammation in the 
head or cold affecting the nose. 
• Excessive indulgence in sexual intercourse 
• Body heat is transmitted to head 
• Entry of minute particles of dust or smoke into the nostrils 
• Excessive application of heat or cold 
• Voluntary retention of stools and urine 
• Diseases of the nose. 
 
Ofibqe<!Lx<Gxqgt<< < << < << < <!
! sqk<k!lVk<Kul<?!Ofib<!fimz<!Ofib<!Lkz<!fimz<!hGkq II.  
1. &g<gqz<! yV! ujg! wiqs<sz<?! fjls<sz<! kir<g! LcbiK?! &g<G!
Ljejb!ncg<gc!Okb<k<K!squg<gs<!osb<kz</!
2. g{<gt<!squf<K!g{<{QI!uckz<!
3. &g<gjmk<kix<Ohiz<!OhSkz</!
4. gikjmk<kz<?!gikqz<!fjls<sz</!
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5. kjz!Ofib<!
6. &s<S!dt<!uir<g!outquqm!sqvll<!
7. &g<gqz<!-Vf<K!heqfQI!Ohiz<!uckz</!
!
CLINICAL FEATURES 
1. According to Yugi vaithiya kaviyam 
 sk<Ok!bqVlz<!Kl<lz<!szlib<!&g<gqz<fQIhiBl<< < < < < < < Q << < < < < < < Q << < < < < < < Q <!
! Lk<Okhqmiq!LcBh<H!oliVg<gz{<c!hqv{<cVg<Gl<< < < < < < << < < < < < << < < < < < <!
! lx<x!uqbikq!-mr<ogiMg<Gl<!ligqz<!Ogijp!liqk<KuqPl<< < < < < < << < < < < < << < < < < < <!
! fqk<kl<!Ofib<gt<!fqjxf<kqVg<Gl<!hQfQsL!oleziOl< < < < < < < Q Q< < < < < < < Q Q< < < < < < < Q Q !
! Cough, expectoration, sneezing, running nose, pain in the occipital 
region, which persists throughout the days. 
2. According to Athma Ratchamirtham 
 sqvsqz<!geozPf<K!$jzbqz<!Ovigl<< < < << < < << < < <!
! nkqgiqk<K!sQp<OhiZl<!sqvib<!OhiZl<< Q < < < << Q < < < << Q < < < <!
! gi{h<hMl<!yV!uqk!&g<G!Ofib<< < < << < < << < < <!
! Increased heat (pitham) affects head causing pain and purulent discharge 
from the Nose. 
3. NAGAMUNIVAR THALAI NOI MARUTHUVAM AND SIDDHAR 
ARUVAI MARUTHUVAM 
 kjzlqg!uzqg<Gl<!fisq!stquqPoliV!U{<miGl<< < < << < < << < < <!
! fzqUV!Kl<lZ{<mie<!fim<osuqbqz<!uvTl<fisq< < < < < << < < < < << < < < < < !
! ljzUxk<!kqv{<M!uqPl<!uiBOl!fijtL{<miz<< < < < << < < < << < < < <!
! ohzLx!&g<gjmg<Gl<!hQeQs!< < < Q Q< < < Q Q< < < Q Q ole<X!OkOv<<< ; 
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!
! kjzBr<!gek<K!uzqogi{<M!stqOhiei!six<xqv{<M!uqPl<< < < < < << < < < < << < < < < <!
! njzB!oliVh<Ohi!oziVgiZ!lXkqh<!hmOu!lixiK< << << < !
! GjzBx<!ogmiK!hiqgiv!fqbkqh<hmOu!osb<Kuiqz<< < < << < < << < < <!
! okijzBR<!osie<Oeil<!hQeQsLl<;< < < Q Q << < < Q Q << < < Q Q < !
• Severe head ache 
• Rhinitis 
• Sneezing 
• Dryness of nose 
• Halitosis 
• Severe nasal block 
• Head ache 
• Expectoration 
4. AGASTHIYAR 2000 
 g{<m!Lgr<gi!Kr<gvr<!K~IuK!Ohizk<< < < < << < < < << < < < <!
! K{<mLf<!kqeUl<!hk<kq!Kl<lqOb!k{<{QI!uQp<f<K< < < < < < Q Q < << < < < < < Q Q < << < < < < < Q Q < < !
! l{<jmBr<!gek<K!ofif<K!uikLl<!hjgg<Gligqz<< < < < < < << < < < < < << < < < < < <!
! L{<mglkqg<G!liOk!&g<GfQI!hib<s<sz<!Ohil<< < < Q < < < << < < Q < < < << < < Q < < < <!
• Throat, ear and facial irritation!
• Itching in the nose!
• Sneezing!
• Running nose!
• Heaviness of Head!
• Head ache!
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!
5. NOI NAADAL NOI MUDHAL NAADAL PART 2 
• Itching and irritation in the nose results in rubbing the tip of the nose 
which becomes markedly red, tense, tender.!
• Redness and lacrimation of the eyes.!
• Nasal obstruction!
• Itching and blockage of ears!
• Difficulty in breathing!
• Profuse watery discharge from the nose!
• Head ache!
6. ATHAMA RATCHAMIRTHA SARA SANGIRAGAM 
• Watery discharge from the nose!
• Itching in the occipital region and face due to exposure to cold air.!
• Irritation in the nose.!
• Frequent sneezing!
• Heaviness of the head and headache.!
7. T.V.SAMBASIVAM PILLAI MARUTHUVA AGARATHI 
• Watery discharge from the nose 
• Sneezing in the rainy season. 
• Itching in the occipital region and face. 
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CLASSIFICATION OF PEENISAM 
 According to SIDDHA MARUTHUVAM and NOI NADAL NOI 
MUDHAL NADAL – PART I Peenisam is 9 types. 
1. Vali peenisam 
2. Azhal peenisam 
3. Kabha peenisam 
4. Neer peenisam 
5. Kuruthi peenisam 
6. Seezh peenisam 
7. Sirai peenisam 
8. Mulai peenisam 
9. Kazhuthu peenisam 
According to THANVANTHIRI VAITHIYAM Peenisam  is of 10 types 
1. Vatha peenisam 
2. Pitha peenisam 
3. Kabha  peenisam 
4. Vatha pitha peenisam 
5. Vatha kaba peenisam 
6. Pitha kaba peenisam 
7. Mukkutra peenisam 
8. Sala peenisam 
9. Ratha peenisam 
10. Varatchi peenisam 
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According to ATHMA RATCHAMIRTHA SARA SANGIRAGAM 
peenisam is 8 types 
 “gih<hie!uik!hQeqsf<kieiGl<< Q < << Q < << Q < <!
! ! gVkqb!OkiI!hqk<k!hQeqsLliGl<< Q << Q << Q <!
! uih<hie!sqOzk<l!hQeqsLliGl<< < Q << < Q << < Q <!
! ! uVk<k!fQIh<hQeqslil<!sQh<hQeqsl<< Q < Q < Q < Q << Q < Q < Q < Q << Q < Q < Q < Q <!
! Osh<hie!Ukqv!hQeqsLliGl<< Q << Q << Q <!
! ! ospqh<hie!sqxih<!hQeqs!&z!hQeqslil<< < Q Q << < Q Q << < Q Q <!
! Nh<hie!g{<!hQeqs!kieiGl<< < Q << < Q << < Q <!
! ! nh<hOe!obm<M!uqk!kq{<< < << < << < <{liOl”!
2/Vatha peenisam 
2. Pitha peenisam 
3. Silethma peenisam 
4. Neer peenisam 
5. Ratha peenisam 
6. Seezh peenisam 
7. Sirai peenisam 
8. Mulai peenisam 
According to T.V. SAMBASIVAM PILLAI MARUTHUVA AGARATHI 
peenisam is 7 types 
2/Vatha peenisam 
2. Pitha peenisam 
3. Silethma peenisam 
4.  Seezh peenisam 
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5. Sirai peenisam 
6. Neer peenisam 
7. Ratha peenisam 
According to Jeeva ratchamirtham peenisam is 18 types. 
1. Vatha peenisa rogam 
2. Pitha peenisa rogam 
3. Silethma peenisa rogam 
4. Trithosa peenisa rogam  
5. Ratha peenisa rogam 
6. Thusta peenisa rogam 
7. Athi thumal peenisa rogam 
8. Nasika sosa rogam 
9. Nasikanasa rogam 
10. Kirana barga rogam 
11. Nasika sirava rogam 
12. Abinisa rogam 
13. Nasika thibigai rogam 
14. Poothi nasika rogam 
15. Pooya siranasika rogam 
16. Nasika poodaga rogam 
17. Nasa rasa rogam 
18. Nasika bootha rogam. 
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MUKKUTRA VERUPADUGAL 
• Due to food habits and deranged pitham i.e; pitham raised from its 
nature, which raises the  body heat (Pitham) which inturn increases both 
vatham and kabam. 
• While doing yoga, the vitiated pitham (body heat) along with udhana 
vayu reaches the head where it combines with kabam causes peenisam. 
NAADI NADAI IN PEENISAM 
1) “uqv{Lme<!H{<Hjvg<G!uikhqk<kl<!
! uqkqbx<bi!hQeqsf<kieQ <Q <Q < <!hqk<k!Osk<Kll<!
! ! ! .!hiqH,v{!fic!
3*!hqk<kk<kqz<!Osk<Kl<!fic!
! h{<hie!hqk<kk<kqz<!Osk<Kl!fic!
! ! hiqsqk<ki!zk<kqSv!lqjth<H=jt<<< !
! g{<giK!fbelzl<!fQVlR<st<!
! ! geubqX!ohiVlz<!lR<st<Ofib<!g{<OfiU!
! d{<OhiK!lXk<kz<!-vk<k!uqh<HVkq!kiEl<!
! ! djtlif<k!hQeqsLl<Q <Q <Q <!-vk<k!uQg<gl<!
! f{<hie!gilijz!Osijgouh<H!
! ! f[gquf<k!hzhq{qBl<!f{<[f<kiOe!
! ! ! ! ! ! .!skgfic!
3/!Osk<Klk<kqz<!uikfic!
! g{<miObi!sqOzx<hek<kqz<!uikfic!
! ! gzf<kqMgqz<!ubqX!ohiXlz<!gek<k!uQg<gl<!
! d{<miOzi!Yr<givR<!sk<kq!uqg<gz<!
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! ! dXkqvm<js!uib<Uuzq!sf<kq!Okiml<!
! uq{<miOz!-jth<<<<hqVlz<!Osijh!hi{<M!
! ! uqmhigl<!uqm$jz!hg<guikl<!
! kq{<miM!fisqgi!hQmlQQQ <!gg<gz<!
! ! sqvOfib<gt<< << << <!hzUl<!uf<K!sqg<Gf<!kiOe/!
! ! ! ! ! ! .!skg!fic!
PINIYARI MURAIMAI (Method of diagnosing the disease) 
The method of diagnosis in siddha system is based on 
• Poriyalarithal 
• Pulanal arithal 
• Vinathal 
 Porigal are considered as the five sense organs of perception namely 
 Mei  - Skin 
 Vai  - Tongue 
 Kan  - Eye 
 Mooku - Nose 
 Sevi  - Ear 
  In Kabha peenisam, mei is not affected.  The affected other 
Gnanenthiriyam produces, redness and lacrimation from kan, Running nose 
from mukku and otalgia in sevi. 
   Pulangal are five senses namely touch, smell, sound, taste and sight 
sensation.  Physicians use their pori and pulan to examine the pori and pulan of 
the patient respectively to diagnosis the disease. 
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  Ooru   –  Touch 
Osai   –  sound 
Suvai   –  Taste 
Oli   –  vision 
Natram  –  smell 
  In kabha peenisam, ooru is not affected, but there is diminished 
sensation of sound, taste and smell. 
  Vinathal is obtaining the information regarding the history of the 
diseases, the clinical features etc., from the patient or from immediate relatives 
who are taking care of him, when the patient is not in a position to speak or if 
the patient is a child. 
  The above principle correspond to the methodology of inspection, 
palpation and interrogation methods of modern science in arriving at a clinical 
diagnosis of the disease. 
  Siddha system of medicine has developed a unique method of 
diagnosing the disease is called “Envagai thervugal.” 
  
ENVAGAI THERVUGAL 
  The unique diagnostic principle in Siddha system of Medicine is 
Envagai Thervugal.  Siddhars describe in many of their literatures that envagai 
thervugal is an instrument for a Siddha physician to examine and diagnose a 
patient.  The following paremeters are adopted to diagnose a patient. 
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 Naadi(Pulse) 
 Sparisam (Palpation) 
 Naa(Tongue) 
 Niram (Colour) 
 Mozhi (Speech) 
 Vizhi (Eyes) 
 Malam (Faeces) 
 Moothiram (Urine) 
This has been explained as follows 
 “fic!^<hiqsl<!fi!fqxl<!olipq!uqpq< < << < << < < !
! lzl<!&k<kqvlqju!lVf<K!uviBkl<< < < << < < << < < <”!
! “olb<g<Gxq!fqxf<okieq!uqpqfiuqfzlzl<!jgg<Gxq< < < < << < < < << < < < < ”!
! ! ! ! ! ! ! ! .!Okjvbi<<<<!
According to Agasthiyar Mani 4000, 
 “ngk<KX!Ofijbg<!gvk<kil!zgl<!Ohiz<< < < < << < < < << < < < <!
! hGk<kxquqi<!fich<hiqsl<!okiGk<k!fqxl<< < < < < << < < < < << < < < < <!
! gm<M!ujgs<!osiz<!olipqg{<!g{<mlz!&k<kqvl<fi< < < < < < << < < < < < << < < < < < < !
! wm<Mujg!biZlxq!uQI!)7*< Q< Q< Q !
! ! ! ! ! ! .!ngk<kqbi<!l{q!5111< << << < !
2/!NAADI!
!! Among envagai thervugal the chief parameters for diagnosis is pulse 
reading.  The siddha physician’s fingers resemble a bimanual stethoscope. 
  Pulse can be felt at one inch below the wrist on the radial artery by 
palpating it with physician’s tip of index, middle and ring fingers 
corresponding vatham, pitham and kabam respectively. 
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  The normal ratio (1: ½ : ¼ ) of vatha, Pitha and kaba is altered in 
various diseases.  In Kabha peenisam, the following pulse may be seen, 
 Pitha Vadha  Naadi, Pitha Kaba Naadi, Kaba vadha Naadi 
PITHA VADHA NAADI 
 “sqxh<hie!hqk<kk<kqz<!uikfic< < < << < < << < < < !
! ! OsiqZX!kiK!fm<mLkv!hQjm< Q< Q< Q !
! djxh<higs<!osiqbijlg<Ge<!lR<$jz< < < < << < < < << < < < < !
! ! Bx<x!Svr<gqvi{q!ubqx<xqjvs<sz<!lf<kl<< < < < < < << < < < < < << < < < < < <!
! njxh<hie!Yr<giv!< << << < “HxfQIg<OgijuQ <Q <Q < ”!
! ! Nbislqvg<g!oliM!lbg<g!&Is<js< < << < << < < !
! Ljxg<gib<U!uq< << << < ]!uQg<gl<!&zuib<UQ < < <Q < < <Q < < < !
! ! Lvmie!Ofib<hzU!LMGl<!h{<Oh/< < << < << < < ”!
       - skg!fic!
PITHA KABA NAADI!!
! “h{<hi<<< e!hqk<kk<kz<!Osk<Kl!fic< < < << < < << < < < !
! ! hiqsqk<kizk<kqSvlqjth<H!=jt< < << < << < < !
! g{<!giK!fbe!lzl<!fQ!VlR<st<< < Q < << < Q < << < Q < <!
! ! geubqX!ohiVlz<!lR<st<!Ofib<!g{<O{iU< < < < << < < < << < < < < !
! d{<!OhiK!lXk<kz<!vk<k!uqh<HVkq!kiEl<?< < < < < << < < < < << < < < < < !
! ! djtlif<jk!<<< ‘hQesLl<Q <Q <Q <’!vk<k!uQg<gl<< Q < << Q < << Q < <!
! f{<hie!gilijz!Osijg!ouh<H< << << < !
! ! f[gq!uf<k!hz!hq{qBl<!f{<[k<kiOe< < < << < < << < < < ”/!
! ! ! ! ! ! ! ! .!skgfic!
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KABA VATHA NAADI 
 “g{<miObi!sqOzx<hek<kqz<!uikfic< < < << < < << < < < !
! ! gzf<kqMgqz<!ubqX!ohiVlz<!gek<k!uQg<gl<< < < < Q < << < < < Q < << < < < Q < <!
! d{<miOzi!Yr<giv!sk<kq!uqg<gz<< < < < << < < < << < < < <!
! ! dXkqvm<js!uib<U!uzq!se<eqOkiml<< < < << < < << < < <!
! uq{<miOz!-jth<hqVlz<!Osijg!hi{<M< < < << < < << < < < !
! ! uqmhigl<!uqm$jz!hg<guikl<< < << < << < <!
! kq{<miM!fisqgi!hQ< Q< Q< Qmr<gg<gz<< < << < << < <!
! ! sqvOfib<gt<!hzUl<!uf<K!sqg<G< < < < << < < < << < < < < f<kiOe<<< ”/!
! ! ! ! ! ! ! .!skgfic!
SPARISAM 
 By touching the skin and various parts of the body, the physician can 
rule out various abnormalities. 
 In Kabha peenisam the inate warmth of the body is increased. 
 In Kabha peenisam, the tenderness present in frontal and maxillary 
region is elicited.   
NAA 
 Colour, coating, dehydration, ulcer, fissure, deviation, movements, 
variations in taste and the conditions of gum and teeth can be noted by 
examining the tongue. 
 In Kabha peenisam, excessive salivation and tasteless of tongue is 
present. 
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NIRAM 
 Pallor, cyanosis, yellowish and other discolouration of the skin should 
be noted.  The type of the body is confirmed by the skin colour whether in 
black (vadha), red (or) yellow (pitha), white (kaba) and mixed colours (mixed 
humours) 
Yugi explains as follows, 
 “Okgk<kq!eqxf<kiEf<!osh<hg<!OgtQi<< < < < < Q << < < < < Q << < < < < Q <!
! ! sqXjlbib<!uikf<kie<!gXk<kq!Vg<Gl<< < < < < << < < < < << < < < < <!
! Ohigk<kqe<!hqk<kfqx!lR<s!tiGl<< < < < << < < < << < < < <!
! ! ohiVR<!Osm<h!Ovigqg<G!ouT< < << < << < < h<H!liGl<< << << <!
! higk<kqe<!okif<kOvi!gqg<G!kiEl<< < < < << < < < << < < < <!
! ! hzhzu{<<<<!{Lligqh<!hcf<K!fqx<Gl<< < < << < < << < < <”!
! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q< << << < !
  In Kabha peenisam, the skin colour depends upon the patient’s body 
condition. 
MOZHI 
 In examination of speech, the high (or) low pitched voice, slurred 
speech, aphasia, Dysarthria, nasal speech, hoarseness of voice  can be noted. 
 In Kabha peenisam, speech may be low pitched due to nasal congestion. 
According to Agasthiyar Mani 4000, 
 “hzOvigq!uiIk<jkh<!hzuqklil<!uikk<< < < << < < << < < <!
! ! kjzOvigq!uiIk<jks<!slliGl<!< < << < << < < .!fqjzgmf<k<<< !
! hqk<kOvi!gqg<G!dbi<f<k!Ohs<S{<mil<!sqOzm<< < < < < < < << < < < < < < << < < < < < < <Mlf<kie<< << << <!
! ! sk<kl<=!es<Svlil<!kie<< < < < << < < < << < < < <”/!
! ! ! ! ! ! .!ngk<kqbi<!l{q!5111/< << << < !
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 Agasthiyar says – The high pitched voice in pitha, low pitched voice in 
kabha and loud voice in vadha patients. 
 
VIZHI 
 Discolouration of eyes, sunking, swelling, lacrimation, ulceration, 
falling of eye lids, swelling and ulceration, falling of eye lashes, vision, 
condition of cornea, conjunctiva and pupils can be examined.  Both motor and 
sensory disturbances of eyes are noted. 
 According to Yugi vaithiya chinthamani, 
 “uqiqk<kqm<m!uikole<x!O< < << < << < < vigqg<!Gk<kie<< < << < << < <!
! ! lQxqOb!g{<gXk<Kk<!k{<{QI!hiBl<Q < < < < Q <Q < < < < Q <Q < < < < Q <!
! hiqk<kqm<m!hbqk<kqb!Ovi!gqg<Gg<!gie<< < < < < << < < < < << < < < < <!
! ! hs<ose<X!squf<kqVg<GR<!Osm<h!Ovigq< < < < < << < < < < << < < < < < !
! hqiqk<kqm<m!hQjtsiVl<!ouTk<kq!Vg<Gl<< < Q < < < << < Q < < < << < Q < < < <!
! ! ohVR<se<eq!uikOvi!gqg<Gr<!g{<kie<< < < < < << < < < < << < < < < <!
! giqk<kqm<Ms<!squf<Khs<!ose<xq!Vg<Gl<< < < < < < < << < < < < < < << < < < < < < <!
! ! gilijz!Ovigqg<G!hSl<<< R<s!tiOl<<< ”!
  Above verse states that eyes are in black colour with tears in vadha, red 
colour in pitha, white colour in kabha patients.  In delirium, mixed colours and 
in jaundice yellow colour are present. 
 In Kabha peenisam, eyes are reddish in colour and lacrimation of eyes 
may be present. 
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MALAM 
 Quantity, odour, constipation, diarrhoea, presence of blood, mucus, pus, 
undigested matter, tenesmus etc., can be noted. 
 In kabha peenisam, the faces is normal in colour. !
MOOTHIRAM 
Neerkuri 
 The urine analysis is done in siddha system according to five 
parameters. 
 “uf<kfQIg<!giqobjm!l{l<Fjv!wR<soze<< Q < < < << Q < < < << Q < < < <!
! !jxf<kqb!Ztuju!bjxGK!LjxOb<<< ”!
! ! ! .!Okjvbi<!fQIg<Gxq!ofb<g<GxqF~z<< Q < < < << Q < < < << Q < < < <!
Niram  - It indicates the colours of urine 
Manam - It indicates the smell of urine 
Edai  - It indicates specific gravity of urine 
Nurai  - It indicates froth of urine 
Enjal  - It indicates quantity of urine 
 In addition frequency, urgency, hesitancy of micturation, painful 
burning urination, any sedimentation and any associated discharge can be 
analysed. 
NORMAL URINE 
 “lqgk<!kch<!Hl<lqgk<!OkxZl<!-e<oxeqz<< < < < < < << < < < < < << < < < < < <!
! Sgk<jkk<!kVl<!olb<s<!ShiufQI!fe<Ox< < < < < Q << < < < < Q << < < < < Q < ”!
! ! ! ! ! .!Okjvbi<!fQIg<Gxq!ofb<g<GxqF~z<< Q < < < << Q < < < << Q < < < <!
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  The normal urine should be in medium weight and moderate clearance. 
NIRAM 
 According to yugi vaithiya chinthamani 
 “h{<hie!<<< uikOvi!gqg<G!&k<vl<< < << < << < <!
! hiiqk<Kk<!oktqf<kqVg<Gl<!ou{<jlbiGl<< < < < < < << < < < < < << < < < < < <!
! h{<hie!hqk<k!Ovi!gqg<G!&k<vl<< < < < << < < < << < < < <!
! liIg<glib<!lR<stqk<Kh<!hsk<kq!Vg<Gl<< < < < < < < << < < < < < < << < < < < < < <!
! ! ! ! .!B,gq!juk<kqb!sqf<kil{q< << << < !
! Yugi described that vadha urine is clear, white in colour,  pitha urine is 
yellow in nature. 
 The Kabha peenisam, the humours  Pitha  and kabham are chiefly 
aggravated and the colour of urine resembles Pitha urine or kabha urine. 
 The same has been quoted as follows, 
 “&k<kqvg<!Gxqgt<!Ogtib<!olipqf<kqMl<!uikl<!ou{<jl< < < < < < < << < < < < < < << < < < < < < < !
! gik<kqv!&k<k!hqk<kR!squh<ohiM!sqXGl< < < << < < << < < < <!fQVl<< Q << Q << Q <”/! !
! ! ! ! ! .!ngk<kqbi<!3111/< << << < !
MANAM 
 It indicates the smell of urine such as pleasant, foul smelling, honey 
smell, fruity smell and flex smell etc., 
 
 “Hziz<!l{r<!glpqx<!H,kqb!hjsg<Og< < < << < < << < < < !
! mzikqjz!bf<fqvg<!G{lqe<!oxeqz<< < < << < < << < < <!
njmBf<kkq!obe<xjkbk<!kie<lqgg<< < < < << < < < << < < < <!
! ogMkq!obeUr<!gqtg<Gf<!SVkqOb< < << < << < < !
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EDAI 
 It indicates the specific gravity of urine 
“nx<hLl<!gelx<!xkqokeq!UXoleqe<< < < << < < << < < <!
ux<HX!sQktl<!le<eqg<!gek<Kg<< Q < < < < << Q < < < < << Q < < < < <!
ghk<jk!-tg<gziz<!g{<m!fQI!-0Ok< < < < Q< < < < Q< < < < Q ”!
! ! ! ! .!Okjvbi<!fQIg<Gxq!ofb<g<Gxq!F~z</< Q < < < << Q < < < << Q < < < < !
! Above verse explains that high specific gravity indicates the affected 
vadham, pitham and kabam. 
NURAI :  
 It indicates thr froth in urine. 
ENJAL 
 It indicates the inorganic and organic deposits like salts, crystals etc.,
 “Yr<gqb!uikk<OkiIg<G!fQIuqPr<!G{Ljvg<gqx<< < < Q < < << < < Q < < << < < Q < < <!
! H,r<ogic!gMk<K!ofif<K!sqXk<Kme<!ohiVlquq< < < < << < < < << < < < < Pl<<<<!
! hir<Gme<!hqk<kk<!OkiIg<Gh<!ohisqbfQI!squf<Kgim<c< < < < < < Q < << < < < < < Q < << < < < < < Q < < !
! Obr<gOu!SXg<gkig!obiqk<Kme<!gMk<K!uqPl<< < < < < << < < < < << < < < < <”!
! ! ! ! ! ! .!ke<uf<kqiq!juk<kqbl<< < < << < < << < < <!
Neikuri 
 “nVf<Kli!xqvkLl<!nuqOvi!klkib<< < << < << < <!
! n0gz<!nzi<kz<!ngizU,{<!kuqi<f<kpf<< < < < < < << < < < < < << < < < < < <!
! Gx<xt!uVf<kq!dxr<gq!jugjx< < << < << < < !
! Ncg<!gzsk<!kiuqOb!kiK!ohb<< < << < << < <!
! okiV!L%Ik<!kg<gjzg<!Gm<hM!fQiqe<< < < < Q << < < < Q << < < < Q <!
! fqxg<Gxq!ofb<Gxq!fqVlqk<kz<!gmOe< < < << < < << < < < ”!
! ! ! ! ! .!Okjvbi<!fQIg<Gxq!ofb<g<Gxq!F~z</< Q < < < << Q < < < << Q < < < < !
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! A drop of gingelly oil is dropped into wide vessel containing the urine, 
to be tested and keep it under the sunlight.  The variations of three humours in 
disease can be diagnosed by the behaviour of gingelly oil on the surface of 
urine. 
 “nvoue!fQ{<cce<!n0Ok!uikl<Q < < <Q < < <Q < < <”!
! The drop of oil lengthening like a snake indicates vadham. 
 “Npq!Ohix<!hvuqe<!n0Ok!hqk<kl<< < < << < < << < < <”!
! If the drop of oil spreads like a ring it indicates pitham. 
 “Lk<okik<K!!fqx<gqe<!olipquke<!ghOl< < < < << < < < << < < < < ”!
! The drop of oil remains floating as a pearl indicates kabam. 
 In thontha state, the oil spreads in mixed form. 
  By careful examination of the urine with gingelly oil, the physicians can 
know whether the disease is curable or not.  For this purpose, siddhars have 
explained various spreading natures of oil on urine surfaces. 
MUKKUTRANGAL 
According to Yugi Vaithiya Chinthamani, 
 “fcg<gqe<x!uikhqk<k!Osm<h!&e<X< < < < << < < < << < < < < !
! ! fzli!uqkqe<hqiqe!Hm<mg<!Ogtib<< < < << < < << < < <!
! ucg<gqe<x!< << << < uiklK!uiBfqjz!gzr<gq<<< !
! ! lk<kqbli!lg<gqeqb!liIg<g!liOl< < << < << < < !
! lig<glil<!hqk<kf<ki!eg<gq!eqjb< < < < << < < < << < < < < !
! ! lsg<gq!juk<K!lib<jgBme<!uVf<kq!jug<Gl<< < < < < < << < < < < < << < < < < < <!
! K~g<gf<kie<!Osm<hlK!szlqG!big<gqk<< < < < < << < < < < << < < < < <!
! ! Kuivr<g!OhiXlqjm!uqmileqx<Gl</< < << < << < < ”!
! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q< << << < !
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! Vatha, pitha and kaba are the three life principles.  They have multiple 
significance in a body. 
VADHAM 
 Vadham represents vayu, mind, dryness, pain, flatulence, sensitiveness, 
lightness and also air.  Vadha is classified into ten forms.  Vadha comprises the 
function of motor and sensory nervous system.  The changes of vadha in kabha 
peenisam are, 
Pranan Affected 
Abanan  Not affected 
Viyanan Affected 
Udhanan  Affected 
Samanan  Affected 
Nagan  Not affected 
Koorman  Affected 
Kirukaran  Affected 
Devathathan  Not affected 
Dhananjeyan  - 
 
 Affected Pranan produces nasal congestion and difficulty in breathing. 
 Affected Viyanan produces head ache, heaviness of the head, pain (or) 
tenderness over the maxillary region. 
 Affected Udhanan produces cough with expectoration. 
 Affected Samanan produces loss of appetite. 
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 Affected Koorman produces watering of the eyes. 
 Affected Kirukaran produces sneezing, profuse watery nasal discharge. 
PITHAM 
 Pitham represents gastric juice, bile, energy, heat, inflammation, anger 
and irritation.  Pitha signifies the function of thermogenesis, metabolism, 
digestion, formation of various secretions and excretions and also gives colour 
to skin and blood.  Five types of pitha and their findings in Kabha peenisam 
are, 
Analapitham  Affected 
Ranjagam Affected 
Alosagam Not affected 
Prasagam Not affected 
Sathagam Affected 
 
  Analapitham in Kabha peenisam is affected which produces loss 
of appetite. 
 Ranjaga pitham may or may not be affected according to the patient’s 
haemolglobin level. 
 Sathagam is affected and there by produces difficulty in performing 
usual works. 
KABHAM 
 Kabham represents feelings of cold, heaviness, mucous discharge and 
saliva.  Five forms of kabam and their findings in Kabha peenisam are,  
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Avalambagam Affected 
Kilethagam Not affected 
Pothagam Not affected 
Tharpagam Affected 
Santhigam Not affected 
 
 Affected Avalambagam produces cough with expectoration. 
 Affected Tharpagam produces irritation and watering of the eyes. 
UDARKATTUGAL 
 They are the basic body structures, which constitute the entire body.  
They are seven in numbers.  Affected body structures in Kabha peenisam are 
Saram Affected 
Senneer Affected 
Oon Not affected 
Kozhuppu Not affected 
Enbu Not affected 
Moolai Not affected 
Sukkilam / 
Suronitham 
Not affected 
 
Affected Saram produces tiredness of body. 
 Affected Senneer produces eosinophilia and raised ESR. 
 Oon and Kozhuppu may or may not be affected according to the 
patient’s nutrition and general body condition. 
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LINE OF TREATMENT 
  In siddha system, the main aim of the treatment is to resolve udarpini 
and manapini (due to alteration in mukkunam). 
 Treatment is not only aimed to cure the disease, but also for the 
prevention of the disease and improving the immunity to overcome the 
seasonal changes and other risk features of kapha peenisam. 
This is said as follows: 
• Kaappu (Prevention) 
• Neekkam (Treatment) 
  The three humours which are responsible for organization, regulation 
and integration of the bodily structures and their physiological functions are 
always kept in a stage of equilibrium by word thought, deed and food of the 
individual. The general aetiological factors for constitutional discomfort said to 
be caused by incompatible diet, mental and physical activities. 
  So it is essential to know the disease and the cause for the onset of 
disease, the nature of the patient, the  severity of illness, the seasons and time 
of the ocurrence of the disease must be observed. 
The line of treatment consist of 
• Drug for the disease 
• Dietary regimen 
  In the case of kapha peenisam the medicines should be given to the 
vitiated kabam and pitham. 
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DIET AND RESTRICTIONS 
“hk<kqbr<!Ogipq!Lm<jm!hSl<hiz<< < < < << < < < << < < < <! !
Lk<kofb<!LVr<jgbqjz< < << < << < < !
lx<Xl<!fqgiqz<!gk<kqiqg<!%m<Ml<< < < < < < << < < < < < << < < < < < <!
hk<KOl!Kujv!kiEl<!h{<hie!hQeqsl<!OhiOl< < < Q << < < Q << < < Q < ”!
! ! ! ! ! .!G{himl<!himz<!w{<!454< < << < << < < !
Egg, milk, castor oil, moringa leaf, brinjal can be taken in peenisanoi. 
Diets should be taken 
• Pepper 
• Karisalai 
• Thoothuvelai 
• Manathakkali 
• Murugaikai 
• Karunai 
• Neelikai 
Diet should be avoided 
• Buttermilk 
• Ice cream 
• Lemon juice 
• Cool soft drinks 
• Bottleguard 
• Pumpkin 
Advices to be followed 
• Avoid polluted places and cold environment. 
• Use hot water for drinking and sanitary purpose. 
• Avoid sleeping during day time on the day of oil bath. 
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MODERN ASPECT 
ANATOMY AND PHYSIOLOGY OF PARANASAL SINUSES 
 
 
LATERAL VIEW 
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 SINUSES GROSS ANATOMY 
The Latin word Sinuses means Curve, Hollow or Fold 
1. Cavity within a bone 
2. Canal or passage leading to an abscess 
3. Any cavity having relatively a narrow opening 
  PARANASAL SINUSES (PNS) are air filled spaces in the bone of the 
facial skeleton Nasal mucous membrane as well as lining of nasal sinus are 
lined by respiratory epithelium (pseudostratified columnar ciliated cells).  
Mucous and serous glands underlie the mucous membrane.  All of them open 
into the nasal cavity through its lateral wall . 
Paranasal sinuses (PNS) are divided into 2 groups 
1. Anterior group 
• Frontal air sinus 
• Maxillary air sinus 
• Anterior ethmoidal air sinuses 
Anterior group drains into the middle meatus 
2. Posterior group 
• Posterior ethmoidal 
• Sphenoidal sinus 
Posterior group drains into the superior meatus and spheno-ethmoidal 
recess. 
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The nasal turbinates 
 There are three nasal turbinates the superior, middle and inferior and 
rarely , a fourth the supreme. 
The functions of the turbinate are 
1. Regulate the intranasal pressure 
2. Provide humidification 
3. Facilitate mucus secretion 
4. Provide olfaction 
5. Absorbs shocks 
6. Deminishes the skull weight 
7. Resonance the voice. 
DEVELOPMENT OF PNS 
 Maxillary and ethmoid sinuses are present at birth while the 
sphenoidal sinus is rudimentary at birth and is recognizable at 8 
years of age. 
 The frontal and spenoidal sinuses start their growth after 3 years. 
 Maxillary and ethmoidal sinuses are fully developed at the age of 12. 
 Frontal sinuses are fully developed at the age of 18-20 
ANTERIOR GROUP OF PARANASAL SINUSES (PNS) 
1. FRONTAL SINUSES 
 Frontal sinuses are two in numbers and are of unequal size divided by a 
bony septum which is seldom in midline. 
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SITUATION 
 It lies in the frontal bone deep to the superciliary arch.  It extends above 
the medial end of the eyebrow and backwards in the medial part of roof of the 
orbit.  It opens into the middle meatus of nose at the anterior end of hiatus 
semilunaris either through ethmoidal infundibulum or through fronto-nasal 
duct. 
Blood and nerve supply 
 It is supplied by supra orbital artery, supra orbital vein and supra orbital 
nerve. 
Lymphatic Drainage – to the submandibular nodes. 
2. MAXILLARY SINUS 
 Maxillary sinus is the largest of all paranasal sinuses and is the first PNS 
to develop.  It is also called antrum of Highmore. 
SITUATION  
 Maxillary sinus lies in the body of the maxilla. 
 It is pyramidal in shape, its apex directed laterally into the zygomatic 
process of the maxilla and base forming the lateral wall of nose. 
Arterial supply is by branches of maxillary, facial and greater palatine 
arteries. 
Venous drainage is by anterior facial vein and pterygoid venous plexus. 
Nerve supply 
 Maxillary nerve through supra-alveolar, anterior palatine and infra 
orbital nerves.  Secreto motor fibres relay through pterygopalatine ganglion. 
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3. ETHMOIDAL SINUS 
 There are 8- 18 inter communicating spaces which are present from 
birth. 
 
SITUATION 
 It lies within the lateral part of ethmoid bone situated between the nasal 
cavity and the orbit giving it a honey comb appearance called the ethmoidal 
labyrinth.  Each sinus is pyramidal in shape.  They are completed from above 
by orbital plate of frontal bone, from behind by the sphenoidal conchae and the 
orbital process of the palatine bone and anteriorly by the lacrimal bone. 
These are divided into two groups 
1. Anterior smaller group (but numerous air cells) consisting of agger cells, 
bulbar cells and frontal cells which open into upper part of hiatus 
semilunaris in the middle meatus.  (bulla ethmoidale also called as 
middle ethmoidal group of sinuses). 
 
POSTERIOR GROUP OF PNS 
1. POSTERIOR ETHMOIDAL SINUS 
 Posterior group of ethmoidal sinus is larger (with a few cells).  It opens 
into the superior meatus of nose.  Optic nerve lies in close proximity to these 
cells. 
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Blood and nerve supply 
 It is supplied by anterior and posterior branches of ophthalmic and 
spheno-palatine artery (which lies near the roof of the sinus and should be 
taken care of during ethmoidectomy). 
  Venous drainage is by corresponding veins. 
  Nerve supply is by branches of maxillary and ophthalmic nerve (naso 
ciliary branch) which form the anterior and posterior ethmoidal nerves. 
 
2. SPHENOID SINUS 
 The capacity of sphenoid sinus varies from 0.5ml to 30ml with an 
average of 7.5ml. 
SITUATION 
 The right and left sphenoidal sinuses are usually un-equal in size which 
lies within the body of the sphenoid bone separated by a septum. 
 It is superiorly related to optic chiasma and hypophysis cerebri and 
laterally to the internal carotid artery and the cavernous sinus. 
 Ostium lies in the upper part of anterior wall and opens into the spheno 
ethmoidal recess.  Bones of bertin also called sphenoidal turbinates initially 
cover the anterior wall of sinuses; but after 10 years fuse with it. 
Types – Sellar, Presellar, Mixed and Conchal with sellar. 
  Blood and nerve supply: It is supplied by Posterior ethmoid and 
spheno-palatine arteries and drained by veins of nasal cavity.  Nerves by 
branches of spheno-palatine ganglion. 
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OSTEO-MEATAL COMPLEX 
  A common pathway for drainage and ventilation of frontal, maxillary 
and anterior ethmoidal sinus. 
A functional entity that includes 
a. Middle turbinate 
b. Hiatus semilunaris 
c. Uncinate process 
d. Ethomoidal bullae 
e. Infundibulum 
Ethmoidal bullae-Rounded elevation produced by the underlying middle 
ethmoidal sinus. 
 Hiatus semilunaris – A deep semicircular sulcus below the bulla 
 Infundibulum – A short pasage at the anterior end of hiatus semilunaris 
 Uncinate process- A curved lamina projecting from the ethmoidal 
labyrinth and forms the medial wall of maxillary sinus. 
OSTEOMEATAL COMPLEX 
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FRONTAL SINUS COMMUNICATIONS 
 It opens into the middle meatus of nose at the anterior end of the hiatus 
semilunaris, either through the infundibulum or through the frontonasal duct. 
 The right and left sinuses are usually unequal in size separated by a thin 
plate of bone.  The sinuses are better developed in males than females.  It is 
lined with columnar epithelium. 
 
MAXILLARY SINUS COMMUNICATIONS: 
 It is lined with ciliated columnar epithelium; it opens into the middle 
meatus of the nose in the lateral part of the hiatus semilunaris and the opening 
lies just below the bulla ethmoidalis.  The openings are near the roof than the 
floor of the sinus.  So the opening is situtated much higher than the floor of the 
sinus in disadvantageous position for the natural drainage.  It is richly provided 
with glands which are chiefly situated around the ostium. 
 
ETHMOIDAL SINUS COMMUNICATION: 
 Each sinus opens into the spheno-ethmoidal recess and opens into the 
superior meatus of nose. 
PHYSIOLOGY –PARANASALSINUSES 
 PNS are lined by mucosal blanket.  Mucosal blanket is of 2 layers a 
superficial viscous and underlying serous layer.  Mucosa constantly produces 
mucus- a pint a day which is constantly propelled backwards by the cilia to the 
posterior chonae, whence it is swallowed, usually unnoticed. 
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SINUSITIS 
Sinusitis comes from latin ‘sinuo’ meaning “bend, wind, curve” and 
greek its meaning “pertaining to”. 
 It is the inflammation of mucosal lining of paranasal sinuses.  
Inflammation may be suppurative or non suppurative.  Although most cases of 
sinusitis involve more than one sinus, maxillary sinus is the most commonly 
involved, followed in frequency by the ethmoid, frontal and sphenoid sinuses.  
Sinusitis affects the tremendous proportion of population, accounts for millions 
of visits to primary care physicians each year. 
 
Epidemiology 
 More than 120 millions of Indians suffer from atleast one episode of 
acute sinusitis each year.  extrapolated prevalance of sinusitis in India is 
1,065,07,607.  It is fifth leading diagnosis for which antibiotics are prescribed 
in India. 
Pathophysiology 
  The physiology of normal sinuses is maintained by three components 
that allow effective and continuous clearance of secretion predisposition to 
bacterial sinusitis occurs when any of the following three components gets 
disturbed. 
a. Normal secretion of sinus 
b. Properly functioning cilia 
c. Patent sinus ostia 
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PATHOLOGY OF SINUSES 
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Due to infection the cilia gets damaged, which results in inadequate 
drainage of sinus cavity, especially the maxillary sinus, where the ostium is 
situated.  The stagnated secretion lead to reinfection. 
Pan sinusitis 
 Inflammation process occurs in all the sinuses resulting is pan sinusitis. 
 Four pairs of sinuses, known as paranasal air sinuses, connect to the 
nasal passage. 
 Frontal sinuses which is present behind forehead. 
 Maxillary sinuses which is present behind cheekbones. 
 Ethmoid sinuses present behind the nose 
 Sphenoid sinuses present behind the eyes. 
When these sinuses are blocked or too much mucus are produced in 
the chambers, bacteria and other germs can grow more easily, leading to 
infection and inflammation. 
CLASSIFICATION 
 It is typically classified by duration of illness, by etiology and when 
infections occurs by the offending pathogen type 
 Acute sinusitis 
 Subacute sinusitis 
 Chronic sinusitis 
 Recurrent 
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ACUTE SINUSITIS 
DEFINITION 
 Acute sinusitis is defined as sinusitis that often lasts upto 4 weeks.  It 
results once the normal defences of mucociliary blanket are breached by 
viruses and secondary invasion by bacteria takes place.  Acute sinusitis is 
generally a complication of acute or allergic rhinitis and rarely secondary to 
dental sepsis. 
 Sinusitis is often classified in terms of locations where all they occur. 
• Acute maxillary sinusitis 
• Acute ethmoiditis 
• Acute frontal sinusitis 
• Acute sphenoiditis 
 
AETIOLOGY: 
• Trauma to sinuses 
• Swimming and bathing 
• General diseases like influenza, whooping cough, pneumonia 
• Infections; 
1. Nasal infections-Hay fever, Acute rhinitis associated with 
common cold. 
2. Pharyngeal Infections-Tonsilitis, Adenoiditis in children. 
3. Tooth infections – Chronic dental infections, Periodental 
abscess and sometimes tooth extraction. 
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PREDISPOSING FACTORS 
• Hay fever and other allergic conditions 
• A nasal passage abnormality-deviated nasal septum, nasal polyps or 
tumours. 
• Medical conditions like cystic fibrosis, gastro esophageal reflux disease, 
auto immune disorder. 
• Regular exposure to pollutants such as cigarette smoke. 
• Dental sepsis. 
BACTERIOLOGY 
Viruses: (90-98% of acute sinusitis) 
• Rhino virus 
• Parainfluenzae I and II 
• Enteric cytopathogenic human orphan (ECHO) 28 
• Coxsackie A 21 
• Respiratory syncitial virus 
Bacteria 
• Haemophilus influenza (48%) 
• Pneumococci (29%) 
• Staphylococci (6.6%) 
• Streptococci 
• Escherichia coli 
• Micrococcus catarrhalis 
• Bacillus pfeiffer 
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Specific infections: 
 Due to fungi, tuberculosis and leprosy. 
PATHOLOGY 
Passes through five stages, 
 Catarrhal stage 
 Exudative stage 
 Suppurative stage 
 Stage of complications 
 Stage of resolution 
Clinically it may be catarrhal type or suppurative type. 
CLINICAL FEATURES 
General symptoms 
• Malaise 
• Headache 
• Fever (not very high) 
• Sore throat 
• Facial pain 
• Peri orbital odema 
Local symptoms 
• Feeling of discomfort in postnasal space. 
• Nasal obstruction 
• Loss of vocal resonance 
• Loss of sense of smell 
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• Nasal or postnasal discharge or drip 
• Cough 
• Sneezing 
• Pain in the sinuses is often classified in terms of location 
o Antral pain: Along the infraorbital margins and referred to the 
upper teeth or gums on the affected side. 
o Ethmoidal pain: Over bridge of the nose and inner canthus of eye 
and is referred to parietal eminence. 
o Frontal sinus pain: Localised to forehead and pain is periodical in 
nature i.e. Starts an hour or two after getting up from bed and 
vanishes during afternoon. 
o Sphenoidal pain: Gives rise to occipital or vertical headache and 
sometimes referred to the mastoid process.  Pain may be felt 
behind the eyeball due to close proximity with Vth nerve. 
Signs: 
• Flushing of cheeks with swelling of cheeks which may spread into lower 
eye lid in maxillary sinusitis.  Upper eye lid may be swollen in Frontal 
sinusitis.  Ethmoiditis may give rise to swelling at the inner canthus of 
the same eye. 
• Tenderness over the affected sinus 
1. Cheek  : Maxillary sinusitis 
2. Floor of sinus : Frontal sinusitis 
3. Inner canthus : Ethmoidal sinusitis 
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• Anterior rhinoscopy: Red, shiny and swollen mucous membrane near 
the ostium of the sinus and trickle of pus may also be seen. 
 
INVESTIGATIONS: 
1. Haematology – TC,DC and ESR are increased 
2. Sputum Culture sensitivity Test 
3. Trans illumination Test 
 Maxillary sinus – absence of infra orbital crescent of light and 
papillary glow absence indicate sinusitis. 
 Frontal sinus illumination is not very informative. 
4. X-Ray PNS- to demonstrate fluid level, pus or opacity. 
5. CT scan-Coronal CT may show thickening of mucosa or opacification 
with occlusion of maxillary infundibulum 
DIFFERENTIONAL DIAGNOSIS 
1. Dental neuralgias, carries, apical infections or abscess. 
2. Temporo mandibular neuralgia (costen syndrome) due to stress and 
strain of tympanic membrane. 
3. Trigeminal neuralgia-it is severe and paroxysmal 
4. Migraine-unilateral and frontal pain 
5. Temporal arteritis-pain over the course of temporal artery which is 
palpable and tender to touch. 
6. Naso – pharyngeal tumours 
7. Brain stem lesions 
8. Herpetic and post herpetic neuralgia may stimulate sinusitis 
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9. Insect bite 
10. Neoplasm of the sinuses. 
TREATMENT 
Prophylactic Treatment 
1. Strengthen first line of defense i.e. mucous/cilliary blanket. 
2. Sunshine, good ventilation and proper humidity. 
3. Good diet rich in vitamins 
4. Avoid swimming in cold water. 
5. Use vaccines (autogenous vaccines) 
Medical treatment 
 Antibiotics 
Local decongestants 
Analgesics 
Surgical Treatment 
 Limited surgery is also done in case of impending complications such as 
orbital cellulitis. 
COMPLICATIONS OF ACUTE SINUSITIS 
• Osteomyelitis of maxilla and frontal bone 
• Orbital cellulitis 
• Orbital abscess formation 
• Intracranial complications like cavernous sinus thrombosis, meningitis 
and intracranial abscess. 
• Chronic sinusitis 
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• Middle ear infections 
• Pharyngitis 
• Laryngitis/Tracheobronchitis 
• Mucocele/Pyocele 
• Oroantral fistula 
PREVENTION 
• Avoid upper respiratory tract infections 
• Carefully manage your allergies. 
• Avoid cigarette smoke and polluted air. 
• Use a humidifier. 
ACUTE RECURRENT SINUSITIS 
 This is quite common. Each attacks clears up totally before the next 
commences.  The mucosa of the sinus returns to normal between attacks. 
 The aetiological factors include, 
• Poor resistance 
• Anatomical abnormalities 
• Recurrent viral upper respiratory tract infections. 
CHRONIC SINUSITIS 
 It is a chronic inflammation of mucous membrane which has resulted in 
irreversible, usually degenerative changes.  Symptoms lasting for more than 12 
weeks.  The illness is most commonly associated with either bacteria or fungi.  
Patients often suffer significant morbidity, sometimes over many years. 
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AETIOLOGY 
 Chronic sinusities follows acute condition, the cause of which is same as 
in acute condition. In addition the following causes are also responsible for 
chronic sinusitis. 
• Asthma 
• Chronic bronchitis 
• Chronic bronchiectasis 
PREDISPOSING FACTORS 
• Deviated nasal septum 
• Hypersensitivity reaction 
• Dental sepsis 
• Poor immunity 
• Alcohol 
• Allergens 
Plant pollens 
Drugs 
Dust materials 
• Allergy subjects are more prone to secondary bacterial infections. 
• Inflammatory products itself may act as allergens inducing further 
changes in the mucosa of the nose and PNS. 
• Iatrogenic factors,  naso-gastric or naso-tracheal tubing. 
Pathology 
 According to histological changes in the sinus mucosa is as follows: 
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• Hypertrophic sinusitis inflammation mainly affects the efferent vessels 
and lymphatics.  If repeated attacks occur the venous and lymphatic 
change produce edema and polypoidal mucous membrane. 
• Atrophic sinusitis-Inflammation occurs in the afferent vessels causing 
cellular reaction leading to endarteritis and thrombosis.  Both atrophic 
and hypertrophic types occurs side by side in the same sinus. 
• Papillary sinusitis Metaplasia of ciliated columnar to stratified 
squamous epithelium type.  It is a viral infection. 
• Follicular type small follicles are seen in the mucous membrane of the 
sinuses. 
• Glandular sinusitis-Glandular elements markedly increase in the 
submucosal tissue lining of sinuses. 
Types of chronic sinusitis 
• Simple chronic infective sinusitis – It usually follows a single or 
repeated attacks.  Vasomotor rhinitis and allergy are absent. 
• Mixed infective and vasomotor chronic sinusitis – Vasomotor factor 
is probably primary in most of the patients.  A secondary infection 
results from chronic obstruction of the ostium and polyposis. 
• Fungal sinusitis  - It occurs in traumatic cases with compound fractures 
in uncontrolled diabetics, debilitiated patients such as carcinoma.  Types 
of fungal infections may be Aspergillosis, acinomycosis and 
mucomycosis. 
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Clinical features 
• Nasal symptoms-nasal obstruction, nasal discharge and post nasal drip. 
• Epistaxis 
• Abnormal smell sensations, cacosmia, hyposmia or parosmia. 
• Vestibulitis 
• Excoriations of the skin of nose. 
• Pharyngitis 
• Dryness of throat 
• Tonsillitis 
• Lymphadenitis 
• Otitis media 
• Periodicity of headache is due to secretions accumulating in the sinuses 
during night and then draining away as the patient attains the erect 
posture. 
• Conjunctivitis 
• Fever, cough and hoarseness of voice 
Signs 
Anterior Rhinoscopy 
• It shows red swollen mucosa with pus in the middle meatus which can 
be made to appear by putting the head between the knees with infected 
sinuses upwards and then raising the head again. 
• In ethmoiditis  the middle turbinate may be hypertrophied and polyp 
may be present. 
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• In spheenoid sinusitis the pus may be seen in the olfactory cleft. 
Posterior Rhinoscopy 
• Pool of pus in the upper surface of the palate and in posterior end of 
inferio turbinate indicates infection of anterior group of sinuses. 
Complications of Anterior Group 
• Orbital complications-orbital cellulitis, abscess 
• Mucocele/pyocele 
• Oroantral/sublabial fistulae 
• Intra-cranial complications such as thrombo-phlebitis, brain abscess, 
extradural abscess and basal meningitis. 
• Potts puffy tumour-swelling of the fore-head due to osteomyelitis of 
frontal sinuses which gives moth eaten appearance in X-rays. 
Complications of Posterior Group 
• Superior orbital fissure syndrome 
• Cavernous sinus thrombophlebitis 
• Oro antral fistula 
• Optic neuritis with impaired vision. 
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MATERIALS AND METHODS 
Selection of the patients: 
For this study, 20 patients of both sexes in different age groups, 
suffering with "KabhaPeenisam"(sinusitis) were screened and selected in 
Outpatients department of Pothu Maruthuvam department and admitted in the 
Inpatient ward of Pothu maruthuvam department of Govt. Siddha Medical 
College and  Hospital, Palayamkottai. 
Another 20 patients were also treated with the clinical trial medicine in 
the out  patient department of pothu maruthuvam of Govt. Siddha Medical 
College, Palayamkottai. 
 
Clinical Evaluation: 
 In this study the detailed clinical history, occupation, personal history, 
related past history and food habits were taken from the patients. 
Special efforts were made to evaluate clinical parameters by a detailed 
history taking of the symptoms includes sneezing,  headache, pain in frontal & 
maxillary region, running nose, otalgia, fever, nasal congestion etc. 
The case sheets were prepared based on both siddha and modern 
diagnostic parameters. 
 
Siddha Diagnosis: 
Siddha diagnosis was made with the help of following parameters such 
as Nilam, Paruvakalam, Thegam, Kaalam, Gunam, Poriyal arithal, Pulanal 
arithal, Mukkutram, Seven udarkattukal, Envagai thervugal etc. 
55 
 
And the diagnosis "KabhaPeenisam" would be corelated with 
"Sinusitis" made by the physical examination of the patient as well as by 
laboratory and radiological investigations. 
 
Laboratory Investigations: 
All the cases were subjected to investigations including TC, DC, ESR, 
Hb, Blood Sugar, Urea, Serum Cholesterol, Absolute Eosinophil Count and 
urine test for albumin, sugar, deposits in the laboratory of Govt.Siddha Medical 
College and  Hospital, Palayamkottai. 
 
Radiological Investigations: 
• X-Ray - skull PNS was taken in all the patients to rule out the 
sinusitis. 
These siddha and modern investigations were very useful to assess the   
prognosis of the disease. 
 
Trial Medicines: 
 Perunjchiraka Chooranam  - 2gm, Twice daily after meal.   
 
Reference:        
          Gunapadam Mooligai Vaguppu- Page No: 467,468. 
 
Evaluation of trial medicines: 
The trial medicine was subjected to pharmacological and toxicity study in 
Periyar College of Pharmaceutical Trichy. The microbiological study was done 
by Malar micro Diagnostic centre, Palayamkottai. 
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The observations were made from both 20 Inpatients & 20 out patients 
based on the clinical improvement and investigation parameters. This result 
and observations were properly recorded in the proforma of this clinical study. 
At the time of discharge all the patients were advised to follow the diet 
control, personal hygiene, adequate water intake and mental relaxation by 
yoga, meditation etc. Then they were advised to follow further treatment in the 
outpatients department of Pothu Maruthuvam for follow up study. 
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OBSERVATION AND RESULTS 
  The results were observed regarding the following criteria by clinical 
study on 20 In patients and 20 Out patients, totally 40 patients was carried out 
in this study. 
• Gender distribution 
• Age distribution 
• Kaalam 
•  Chronicity of illness 
• Religion 
• Gunam 
• Thinai 
• Paruvakaalam 
• Occupation 
•  Aetiology 
• Socio-economic status 
• Dietary habits 
• Family history 
• Clinical manifestation 
• Mode of onset 
• Imporigal(Gnanendhiriyam) 
• Kanmendhiriyam 
• Mukkutram 
Derangement of vatham 
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Derangement of pitham 
Derangement of kabam 
• Ezhu udal kattugal 
• Envagai thervugal 
• Neer kuri 
• Nei kuri 
• Radiological investigations 
• Improvement of clinical symptoms 
• Laboratory investigations 
• Gradation of results 
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1. GENDER  DISTRIBUTION. 
Table1 illustrates the distribution of sex  
No. of Cases Percentage  % 
Sl. No Sex 
OP IP OP IP 
1. Male 7 10 35 50 
2. Female 13 10 65 50 
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Inference: Among 40 cases the prevalence of the disease was 
found to be higher in female. 
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2.  AGE DISTRIBUTION.   
Table 2 illustrates the distribution of age. 
No. of .cases Percentage % 
Sl. No 
Age groups 
in years OP IP OP IP 
1. 13 to 20 4 - 20 - 
2. 21 to 30 4 1 20 5 
3. 31 to 40 4 2 20 10 
4. 41 to 50 8 14 40 70 
5. 51 to 60 - 3 - 15 
6. 61 to 70 - - - - 
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Inference: Among 40 cases, the prevalence of the disease was found to 
be higher among the age group of 51-60. 
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3.  KAALAM [Life span]  
 Table 3 illustrates the distribution of Kaalam  
No. of cases Percentage % 
Sl. No Kaalam 
OP IP OP IP 
1. Vatham 
1-33 years 
10 1 50 5 
2. Pitham 
34-66 years 
10 19 50 95 
3. Kabham 
67-100 years 
- - - - 
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 Inference: Among 40 cases the prevalence of the disease was found to 
be higher in Pitha kaalam. 
abha   Y ars 
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4. CHRONICITY OF ILLNESS: 
No. of cases Percentage% 
Sl. No Chronicity of illness 
OP IP OP IP 
1. Upto 1 month 9 4 45 20 
2 2-6 months 6 6 30 30 
3. 6-12 months 4 6 20 30 
4. 12-18 months 1 2 5 10 
5. Above 18 months - 2 - 10 
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   Inference: Among 40 cases, 21 cases had the illness within 1month; 16 cases 
had the illness 2-6 months; 1 case had the illness 6-12 months and 2 cases 
above 18 months. 
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5. RELIGION 
 Table 5 illustrates the distribution of Religion 
No. of. Cases Percentage% 
Sl. No. Religion 
OP IP OP IP 
1. Hindu 15 18 75 90 
2. Christian 2 1 10 5 
3. Muslim 3 1 15 5 
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Inference: Among 40 cases the prevalence of the disease was found to 
be more among  Hindus.  
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6. GUNAM 
 Table 6 illustrates the distribution of gunam  
No. of  cases Percentage % 
Sl. No. Gunam 
OP IP OP IP 
1. Sathuva Gunam - - - - 
2. Rajo Gunam 20 20 100 100 
3. Thamosa Gunam - - - - 
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 Inference: In both OP and IP study cent percentage belongs to Rajo 
Gunam. 
65 
 
7. THINAI. 
 Table 7 illustrates the distribution of the disease among the Thinai 
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 Inference: Among 40 cases Marutha nilam had the higher incidence of 
the disease. 
No. of Cases Percentage% 
Sl. No. Thinai 
OP IP OP IP 
1. Kurinji  - - - - 
2. Mullai 1 2 5 10 
3. Marutham 18 16 90 80 
4. Neithal 1 2 5 10 
5. Paalai - - - - 
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8. PARUVAKAALAM 
 Table 8 illustrates the distribution of the disease among the 
Paruvakaalam. 
No. of Cases Percentage% 
Sl. No. Paruvakaalam 
OP IP OP IP 
1.  Kaar kaalam - - - - 
2.  Koothir kaalam - - - - 
3.  Munpani kaalam 10 - 50 - 
4.  Pinpani kaalam 10 1 50 5 
5.  Elavenil kaalam - 15 - 75 
6.  Muthuvenil kaalam - 4 - 20 
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 Inference: Among 40 cases the occurrence of the disease was found to 
be higher in Munpani and Pinpani kaalam. 
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9. OCCUPATION 
 Table 9 illustrates the distribution of occupation among the patients. 
No. of cases Percentage% 
Sl. No. Occupation 
OP IP OP IP 
1. Farmer 1 1 5 5 
2. Student 4 - 20 - 
3. Beedi Maker 2 4 10 20 
4. House Wife 7 3 35 15 
5. Chemical company - 1 - 5 
6. Cement factory 1 1 5 5 
7. Hotel - 1 - 5 
8. Driver 1 3 5 15 
9. Government employee 1 - 5 - 
10. Labour 2 4 10 20 
11. Miscellaneous 1 2 5 10 
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  Inference: Among 40 cases the most prevalence of the disease occurs 
more in Students, driver, labour and House Wife. 
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10. AETIOLOGICAL FACTORS.   
Table 10 illustrates the Aetiological factors for disease. 
No. of cases Percentage% 
Sl. No. Aetiological  Factors 
OP IP OP IP 
1. Smoking 4 3 20 15 
2.  Cold exposure 12 10 60 50 
3. Husk of grains & Dust 4 7 20 35 
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Inference: The above table showed dust and cold exposure were the 
main aetiological factors among the Patients. 
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11. SOCIO-ECONOMIC STATUS.   
 Table 11 illustrates the socio economic status of the patients. 
No. of cases Percentage% 
Sl. No. Socio- Economic Status 
OP IP OP IP 
1. Poor income group 2 9 10 45 
2. Middle income group 15 10 75 50 
3. Rich income group 3 1 15 5 
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Inference: Among 40 patients, it is observed that the disease occured more 
among Middle income group. 
 
70 
 
 
 
12.  DIETARY HABITS.   
 Table 12 illustrates the distribution of diet among the patients.  
No. of cases Percentage% 
Sl. No. Food habits 
OP IP OP IP 
1. Vegetarian diet 4 2 20 5 
2. Mixed diet 16 18 80 90 
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Inference: The table showed that highest incidence of the disease for 
the patients with mixed diet. 
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13. FAMILY HISTORY: 
 Table 13 illustrates the distribution of family history.  
 
No. of cases Percentage% 
Sl. No. Family History 
OP IP OP IP 
1. Positive 5 3 25 15 
2. Negative 15 17 75 85 
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 Inference: In inpatients 90% have no family history. 
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14. CLINICAL MANIFESTATION: 
 Table 14 illustrates the distribution of clinical manifestation 
No. of cases Percentage% 
Sl. No. Symptoms 
OP IP OP IP 
1. Sneezing 20 18 100 90 
2. Rhinitis 10 8 50 40 
3. Nasal congestion 15 16 75 80 
4. Headache/Heaviness of head 14 10 70 50 
5. Lacrimation 5 6 25 30 
6. Facial pain 7 9 35 45 
7. Fever 1 - 5 - 
8. Otalgia 3 2 15 15 
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Inference: The table shows that most of the patients had Sneezing ,Nasal 
congestion, Headache.  
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15. MODE OF ONSET 
Table 15 illustrates the distribution of Mode of onset of the disease. 
No. of cases Percentage% 
Sl. No. Mode of onset 
OP IP OP IP 
1. Acute  15 10 75 50 
2. Chronic 5 10 25 50 
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Inference: The table showed that the mode of onset was acute as well as  
chronic.  
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16. IMPORIGAL (GNANENDHIRIYAM) 
 Table 16 illustrates the distribution of disease with Imporigal.  
No. of cases Percentage% Sl. No. Imporigal 
(Gnanendhiriyam) OP IP OP IP 
1. Mei 5 6 25 30 
2. Vai - - - - 
3. Kan 8 7 40 35 
4. Mookku 15 13 75 65 
5. Sevi 2 2 75 65 
  
30
35
0 0
45
40
70
60
10
15
0
10
20
30
40
50
60
70
80
OP IP
Cases
Pe
rc
e
n
ta
ge
 
(%
)
Mei Vai Kann Mookku Sevi
 
 Inference: The table showed that Kann and Mookku were affected in 
most of the patient. 
 
75 
 
 
17. KANMENTHIRIYAM 
Table 17 illustrates the distribution of disease with Kanmenthiriyam. 
No. of cases Percentage% 
Sl. No. Kanmenthiriyam 
OP IP OP IP 
1. Kai 3 6 15 30 
2. Kaal 3 4 15 20 
3. Vai - - - - 
4. Eruvai - - - - 
5. Karuvai - - - - 
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Inference: The table showed that kai and  Kaal was affected in most of 
the patients 
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18. MUKKUTRAM 
 18. a. Derangement of vatham. 
No. of cases Percentage%  S
l. No. 
Vatham 
OP IP OP IP 
1. Piraanan 16 18 80 90 
2. Abaanan - - - - 
3. Viyaanan 3 5 15 20 
4. Uthaanan 13 14 65 70 
5. Samaanan  20 20 100 100 
6. Naagan 4 5 20 25 
7. Koorman 8 6 40 30 
8. Kirukaran 20 18 100 90 
9. Devaththan 9 15 45 75 
10. Dhananjayan - - - - 
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Inference: In all the In patients & Out patients Samaanan, Kirukaran 
and Devaththan was affected. 
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18. b. Derangement of Pitham. 
No. of cases Percentage%  S
l. No. 
Pitham 
OP IP OP IP 
1. Analagam 5 7 25 35 
2. Ranjagam 2 6 10 30 
3. Sathagam 12 14 60 70 
4. Prasagam - - - - 
5. Aalosagam - - - - 
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 Inference: The table shows most of the patients affected with Sathagam. 
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18.c. Derangement of Kabam. 
No. of cases Percentage% 
Sl. No. Kabam 
OP IP OP IP 
1. Avalambagam 20 20 100 100 
2. Kilathagam - - - - 
3. Pothagam - - - - 
4. Tharpagam 6 4 30 20 
5. Santhigam 10 4 50 20 
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 Inference: The table showed that the Avalambagam was affected in all 
the patients in this disease. 
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19. Ezhu udal kattugal 
 Table19. Illustrates  the distribution of derangement of ezhu udal 
kattugal. 
No. of cases Percentage% Sl. No. Udal kattugal 
OP IP OP IP 
1. Saaram 20 20 100 100 
2. Senneer 4 5 20 25 
3. Oon - - - - 
4. Kozhuppu 3 7 15 35 
5. Enbu 2 5 10 25 
6. Moolai - - - - 
7. Sukkilam/suronitham - - - - 
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Inference: The table showed that Saaram was affected in all the patients in this 
disease. 
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20. ENVAGAI THERVUAL  
 Table 20 illustrates the distribution of envagai thervugal. 
No. of cases Percentage% 
Sl. No. Envagai thervugal 
OP IP OP IP 
Naadi (Thontha Naadi) 
1. Vadha pitham 12 11 60 55 
2. Vadha kabam - - - - 
3. Pitha vadham 3 2 15 10 
4. Pitha kabam  5 5 25 25 
5. Kabha vadham  - 2 - 10 
1. 
6. Kabha pitham  - - - - 
2. Sparisam 3 5 15 25 
3. Naa 2 6 10 30 
4. Niram - - - - 
5. Mozhi 12 13 60 65 
6. Vizhi 5 6 25 30 
7. Malam - - - - 
8. Moothiram - - - - 
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1.      Vadha pitham 2.      Vadha kabam 3.      Pitha vadham
4.      Pitha kabam 5.      Kaba vadham 6.      Kaba pitham 
Sparisam Naa Niram
Mozhi Vizhi Malam
Moothiram
 
Inference: The table showed Mozhi, Naa, Vizhi  & sparisam were affected in 
most of the patients. In Naadi, Vatha pitham showed higher frequency than the 
others. 
 
 
bha va  Kabha pitham 
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21. NEER KURI  
No of cases Percentage % 
 S.NO Neer kuri 
OP IP OP IP 
1. Niram 3 7 15 35 
2. Manam - - - - 
3 Edai - - - - 
4. Nurai - - - - 
5. Enjal - - - - 
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Inference: The table showed that Manam, Edai, Nurai and Enjal were 
not affected , Niram was affected in 10% of OP patients & 30% of IP patients. 
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22. NEI KURI 
 Table 22 illustrates the distribution of Nei kuri. 
No. of cases Percentage% 
Sl. No. Nei Kuri 
OP IP OP IP 
1. Vatha Neer 3 2 15 10 
2. Pitha Neer 4 5 20 25 
3. Kabha Neer 11 15 55 50 
4. Thontha Neer 2 3 10 15 
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 Inference: The table showed that Kabha Neer was found in most of the 
cases. 
 
 
abha  
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23. Radiological examination: 
Outpatients          Inpatients 
X-Ray PNS No. of 
cases 
Percentage 
No. of 
cases 
Percentage 
Frontal sinusitis  10 50 8 40 
L.Maxillary 
sinusitis 
4 20 4 20 
R.Maxillary 
sinusitis 
4 20 6 30 
Ethmoid sinusitis 2 10 2 10 
Sphenoid sinusitis - - - - 
DNS 4 20 4 20 
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  Inference: The table showed that Frontal Sinusitis was found in most of 
the cases. 
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24. Assessment of Outcome 
 
Out Patients In Patients 
BT  AT  BT  AT  Symptoms 
No. of 
Cases % 
No. of 
caes 
% No. of Cases % No. of % 
Sneezing 20 100 16 80 18 90 15 75 
Rhinitis 10 50 5 25 8 40 5 25 
Nasal 
congestion 15 75 10 50 16 80 12 60 
Headache/ 
heaviness of 
head 
14 70 10 50 10 30 7 35 
Lacrimation 5 25 4 20 6 30 5 25 
Facial pain 7 35 5 25 9 45 6 30 
Fever 1 5 - - - - - - 
Otalgia 3 15 1 5 2 10 1 5 
 
BT – Before treatment 
AT- After treatment 
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Inference 
 Out of 40 patients, sneezing was relieved in 31 patients (77.5%) were 
relieved from sneezing, 10 patients (25%) were relieved from rhinitis, 22 
patients (55%) were relieved from nasal congestion, 17 patients (42.5%) were 
relieved from headache, 9 patients (22.5%) were relieved from lacrimation,             
11 patients (27.5%) from facial pain, and 2 patients (5%) from otalgia. 
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25. Absolute Eosinophil Count (AEC) 
No of cases          Percentage Absolute 
eosinophil count 
(cells/ µl) 
BT AT BT AT 
40-440 31 33 77.5 82.5 
441-600 4 4 20 20 
601-800 3 2 15 10 
801-1000 1 0 5 0 
1001-1500 1 1 5 5 
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Inference 
Before treatment 
  Out of 40 cases, 31 cases (77.5%) the AEC level was between    40 – 
440 cells /µl, in 4 cases (20%) the AEC level was 441-600, in 3 cases (15%) 
AEC level was 601 – 800, in 1 case (5%) AEC level was 801-1000, in 1 case 
(5%) AEC level was 1001-1500. 
After treatment 
Out of 40 cases, 33 cases (82.5%) the AEC level was between   40 – 440 
cells /µl, in 4 cases (20%) the AEC level was 441-600, in 2 cases (10%) AEC 
level was 601 – 800,  in 1 case (5%) AEC level was 1001-1500. 
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26. Gradation of Results: 
 From above all parameters the overall gradation may be as follows. 
Outpatients Inpatients 
Grade 
No.of cases Percentage No.of cases Percentage 
Good 
Response 
17 85 17 85 
Moderate 
Response 
3 15 3 15 
Poor 
Response 
-           - - - 
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Inference: Among Inpatients and out patients 
85% of cases showed good results.  
15% of cases showed Moderate results.  
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Table - I 
CASE SUMMARY OF OUT-PATIENTS 
S.No. OP. No Name Age Sex Occupation 
Duration 
of the 
illness 
Starting 
of 
Treatment 
End of 
Treatment 
No. of 
days 
Treated 
Results 
1. 11006 Abubkhan 45 M Driver 2 Months 02.02.16 04.03.16 31  
2. 11405 Reshma 32 F Housewife 6 Months 03.02.16 06.03.16 32  
3. 11714 Jeyasudha 33 F Beedi Maker 6 Months 14.02.16 08.03.16 32  
4. 12076 Priya 25 F Housewife 8 Months 05.02.16 09.03.16 33  
5. 12421 hanshi 46 F Housewife One Year 06.02.16 09.03.16 32  
6. 12449 Geetha 38 F Housewife 2 Year 06.02.16 09.03.16 32  
7. 12921 Ramesh 38 M Conductor 2 Year 08.02.16 09.03.16 30  
8. 13297 Saiskala 18 F Student 6 Months 09.02.16 09.03.16 29  
9. 13312 Sathiyapriya 18 F Student 18 Months 09.02.16 10.03.16 30  
10. 13375 balasubramanian 41 M Labour 8 Months 09.02.16 10.03.16 30  
11. 14775 Parvathy 49 F Housewife 4 Months 13.02.16 12.03.16 28  
12. 15580 Karthiga 21 F Student 2 Years 16.02.16 17.03.16 30  
13. 15616 Chandra 50 F Housewife 2 Months 16.02.16 17.03.16 30  
14. 16502 Radhakrishnan 50 M Govt. Employee 3 Days 18.02.16 19.03.16 30  
15. 16503 Isakkimuthu 18 M Labour 6 Months 18.02.16 19.03.16 30  
16. 17121 Maheswaran 25 M Cement factory 
work 
4 Days 20.02.16 19.03.16 28  
17. 17169 Arumugapriya 18 F Student 15 Days 20.02.16 20.03.16 29  
18. 18120 Poovathal 43 F Housewife 20 Days 23.02.16 22.03.16 31  
19. 18533 Vani 27 F Beedi Maker 1 Year 24.02.16 27.03.16 32  
20. 18534 Thanikasalam 45 M Farmer 6 Months 24.02.16 27.03.16 32  
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Table - II 
LABORATORY INVESTIGATIONS OF OUT-PATIENTS 
Before Treatment After Treatment 
Absolute Eosinophil 
Count 
S.No OP. No Blood 
Sugar 
mg% 
Blood 
urea 
mg% 
Serum 
Cholesterol 
mg% 
Blood 
Sugar 
mg% 
Blood 
urea 
mg% 
Serum 
Cholesterol 
mg% 
Before 
Treatment 
After 
Treatment 
1. 11006 110 30 200 120 35 190 355 222 
2. 11405 90 17 172 98 20 160 133 122 
3. 11714 108 20 187 107 20 180 144 250 
4. 12076 85 20 120 87 25 130 144 155 
5. 12421 86 20 126 87 20 140 122 222 
6. 12449 82 24 140 83 23 150 368 66 
7. 12921 90 30 180 95 35 170 1060 1336 
8. 13297 80 20 110 88 22 120 55 244 
9. 13312 116 28 250 120 30 240 122 100 
10. 13375 180 20 172 170 24 182 433 520 
11. 14775 79 24 160 90 20 170 133 130 
12. 15580 79 20 140 80 22 140 430 510 
13. 15616 116 28 244 110 30 200 368 200 
14. 16502 101 34 171 80 35 170 440 380 
15. 16503 85 20 170 90 22 160 225 185 
16. 17121 110 30 180 95 30 190 330 280 
17. 17169 89 22 116 88 22 115 410 390 
18. 18120 120 24 160 95 20 170 224 180 
19. 18533 95 35 190 100 30 200 436 333 
20. 18534 110 24 150 98 20 170 44  
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Table - III 
LABORATORY INVESTIGATIONS OF OUT-PATIENTS 
BLOOD INVESTIGATION URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT BEFORE TREATMENT AFTER TREATMENT 
DC% ESR 
mm hrs DC% 
ESR 
mm hrs 
S. 
No OP. No TC Cells/ 
 Cumm P L E 1/2 hr 1hr 
Hb 
gm% 
TC Cells / 
Cumm P L E 1/2 hr 1hr 
Hb 
gm% Alb Sug Dep Alb Sug Dep 
1. 11006 9200 52 36 12 10 25 11 9300 57 36 6 10 25 11.3 Nil Nil NAD Nil Nil NAD 
2. 11405 9000 67 29 4 4 8 10.5 9000 65 35 2 2 4 10 Nil Nil NAD Nil Nil NAD 
3. 11714 9000 68 27 5 3 6 10.5 9100 68 30 2 2 4 10.5 Nil Nil NAD Nil Nil NAD 
4. 12076 9200 60 26 4 12 24 10 9100 65 35 2 4 8 10.5 Nil Nil 1 – 2 pus cells Nil Nil NAD 
5. 12421 8000 67 29 4 6 12 12.5 8000 68 30 2 6 12 12 Nil Nil NAD Nil Nil NAD 
6. 12449 8800 58 28 8 26 55 12 9000 66 30 4 12 24 12 Nil Nil NAD Nil Nil NAD 
7. 12921 8000 55 40 5 2 4 10.8 8100 60 39 1 2 4 10.4 Nil Nil NAD Nil Nil NAD 
8. 13297 7800 58 36 6 8 16 11. 8000 60 36 4 4 8 11.5 Nil Nil NAD Nil Nil NAD 
9. 13312 7400 54 40 6 20 42 11.8 7300 55 42 3 10 20 11.5 Nil Nil NAD Nil Nil NAD 
10. 13375 9000 68 27 5 3 6 14 9000 67 30 3 3 6 13.5 Nil Nil NAD Nil Nil NAD 
11. 14775 8000 50 49 1 9 18 10.8 8100 63 36 1 6 15 10.9 Nil Nil NAD Nil Nil NAD 
12. 15580 8200 50 48 2 2 4 11 8300 55 44 1 2 4 11 Nil Nil NAD Nil Nil NAD 
13. 15616 7800 52 36 12 20 40 11.5 7900 65 30 5 10 20 11.0 Nil Nil NAD Nil Nil NAD 
14. 16502 7400 54 40 6 20 40 10.5 9600 58 40 4 10 20 10.5 Nil Nil 1 – 2 pus cells Nil Nil NAD 
15. 16503 7900 67 25 8 10 20 10.5 7800 65 30 3 5 10 10.5 Nil Nil NAD Nil Nil NAD 
16. 17121 8000 67 29 4 6 12 9.8 8100 68 30 2 3 6 10 Nil Nil 1 – 2 pus cells Nil Nil NAD 
17. 17169 9500 58 38 4 5 11 9.5 9600 60 38 2 2 4 9.8 Nil Nil NAD Nil Nil NAD 
18. 18120 8700 67 30 3 6 12 10 8800 68 30 2 3 6 10.5 Nil Nil NAD Nil Nil NAD 
19. 18533 9000 65 30 5 10 20 10.5 8900 66 32 2 5 10 11 Nil Nil NAD Nil Nil NAD 
20. 18534 8900 68 27 5 6 12 11 8800 68 30 2 3 6 11.2 Nil Nil NAD Nil Nil NAD 
  
  
93 
Table - IV 
CASE SUMMARY OF IN-PATIENTS 
S.No. IP. No Name Age Sex Occupation 
Duration 
of the 
illness 
Starting of 
Treatment 
End of 
Treatment 
No. of 
days 
Treated 
Results 
1. 407 Lakshmi 50 F Beedi Maker 6 Months 16.02.16 10.03.16 23 Good 
2. 1363 Thatchinamoorty 50 M Driver 8 Months 24.05.16 11.06.16 19 Good 
3. 1352 Pitchiapillai 42 M Driver 4 Months 23.05.16 17.06.16 26 Good 
4. 1377 Kaikondan 48 M Hotel 2 Months 25.05.16 14.06.16 21 Good 
5. 1364 Lakshmi 50 F Cement Factory 
worker 
6 Months 23.05.16 02.06.16 11 Good 
6. 1397 Lakshmi 40 F House wife 2 Months 27.05.16 30.05.16 4 Good 
7. 1382 Kalyani 50 M Chemical 
company 
15 days 26.05.16 17.06.16 23 Good 
8. 1468 Ponperumal 49 M Labour 10 days 04.06.16 20.06.16 12 Good 
9. 1471 Subbammal 52 F Beedimaker 20 days 05.06.16 16.06.16 14 Good 
10.  Maragatham 42 F Housewife 1 year 05.06.16 18.06.16 23 Good 
11. 1409 Arumugam 43 F Labour 8 Months 28.05.16 19.06.16 12 Good 
12. 1482 Ravindran 40 M Labour 4 Months 06.06.16 17.06.16 13 Good 
13. 1489 Manoranjitham 43 F Beedi Maker 12 Days 07.06.16 19.06.16 3 Fair 
14. 1516 Vallinayagam 42 M Plumber 20 days 10.06.16 12.06.16 6 Good 
15. 1529 Balkani 43 F Labour 2 Months 12.06.16 17.06.16 4 Good 
16. 1536 Nainar 53 M Driver 10 days 14.06.16 17.06.16 2 Fair 
17. 1579 Pandi 47 M Cement Factory 
worker 
15 days 18.06.16 19.06.16 5 Good 
18. 1578 Chinamani 52 M Farmer 10 days 18.06.16 27.06.16 10 Good 
19. 1559 Rajeswari 23 F Housewife 7 days 15.06.16 22.06.16 8 Good 
20.  Arumugammal 48 F Beedi Maker 2 Months 20.06.16 26.06.16 7 Fair 
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Table V 
LABORATORY INVESTIGATIONS OF IN-PATIENTS 
Before Tratment After Treatment 
Absolute Eosinophil 
Count 
S.No IP.No 
Blood Sugar 
mg% 
Blood urea 
mg% 
Serum 
Cholesterol 
mg% 
Blood sugar 
mg% 
Blood urea 
mg% 
Serum 
Cholesterol 
mg% 
Before 
Treatment 
After 
Treatment 
1. 407 80 20 160 86 22 140 155 100 
2. 1363 90 22 120 80 20 120 144 122 
3. 1352 72 24 153 85 22 155 888 666 
4. 1377 95 25 125 110 24 130 311 305 
5. 1364 107 32 200 91 30 190 633 233 
6. 1397 90 30 190 95 35 200 333 222 
7. 1382 110 35 170 90 30 180 588 122 
8. 1468 121 29 163 119 20 160 122 111 
9. 1471 227 30 217 120 32 200 277 222 
10. 1473 91 22 186 90 21 187 155 166 
11. 1409 114 23 143 110 25 144 644 588 
12. 1482 83 30 141 85 35 180 511 133 
13. 1489 93 36 174 90 32 190 122 101 
14. 1516 120 20 150 80 18 150 333 222 
15. 1529 127 30 217 120 32 200 544 644 
16. 1536 107 32 200 91 32 170 620 480 
17. 1579 85 22 120 80 20 120 340 220 
18. 1578 93 36 174 90 32 180 430 310 
19. 1559 91 22 186 90 21 187 500 405 
20.  100 30 190 110 35 185 140 120 
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Table - VI 
LABORATORY INVESTIGATIONS OF IN-PATIENTS 
BLOOD INVESTIGATION URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT BEFORE TREATMENT AFTER TREATMENT 
DC% ESR 
mm hrs DC% 
ESR 
mm hrs 
S. 
No IP. No 
TC Cells/ 
 Cumm P L E 1/2 hr 1hr 
Hb 
gm% 
TC Cells / 
Cumm P L E 1/2 hr 1hr 
Hb 
gm % Alb Sug Dep Alb Sug Dep 
1 211 11000 68 30 2 8 50 10.8 11000 67 30 3 10 20 10.5 Nil Nil 3-5pus cells Nil Nil NAD 
2 328 7800 64 30 6 4 28 11.8 7300 67 31 2 7 14 11.5 Nil Nil NAD Nil Nil NAD 
3 343 7800 60 35 5 5 10 10.8 7400 65 37 3 5 10 10 Nil Nil NAD Nil Nil NAD 
4 542 8600 53 32 15 6 12 10.7 8500 60 40 5 3 6 10.5 Nil Nil NAD Nil Nil NAD 
5 553 7300 67 27 6 10 24 10 7200 63 32 5 2 4 10 Nil Nil 1 – 2 epi cells Nil Nil NAD 
6 656 9000 60 28 12 20 40 9.7 9100 63 31 8 10 20 9.5 Nil Nil 1-2 pus cells Nil Nil NAD 
7 774 8500 64 27 9 30 60 12.7 8400 64 30 6 15 30 12.5 Nil Nil 1-2 pus cells Nil Nil NAD 
8 778 9000 56 34 10 60 98 10.5 8500 55 40 5 30 60 10.5 Nil Nil NAD Nil Nil NAD 
9 846 8300 68 30 2 2 4 9.5 8200 67 32 1 2 5 9.5 Nil Nil 2-5 pus cells Nil Nil NAD 
10 906 540 67 30 3 24 45 12 5500 67 31 2 20 40 12 Nil Nil NAD Nil Nil NAD 
11 911 9000 65 34 1 4 8 10.5 9000 66 35 1 2 4 10 Nil Nil 1-2 pus cells Nil Nil NAD 
12 969 8300 65 25 10 2 6 10 8200 65 30 5 2 4 10.5 Nil Nil NAD Nil Nil NAD 
13 995 8000 60 38 2 2 4 11 8100 64 35 1 2 4 11 Nil Nil NAD Nil Nil NAD 
14 1043 8000 55 43 2 10 20 12 7900 60 38 2 5 10 11.5 Nil Nil few pus cells Nil Nil NAD 
15 1097 8000 60 38 2 4 8 9.2 8000 65 34 1 2 4 10 Nil Nil NAD Nil Nil NAD 
16 1101 8100 54 40 6 24 48 9 8000 67 30 3 12 24 9 Nil Nil NAD Nil Nil NAD 
17 1106 9000 56 34 10 60 98 10 9100 55 40 5 30 60 10 Nil Nil NAD Nil Nil NAD 
18 1108 8600 67 28 5 2 5 12 8500 60 37 3 2 4 12 Nil Nil NAD Nil Nil NAD 
19 1215 8700 66 21 4 10 20 8.5 8800 60 35 5 5 10 9 Nil Nil 1-2 epi cells Nil Nil NAD 
20 1357 8000 67 30 3 20 40 10 8100 65 33 2 10 20 10 Nil Nil NAD Nil Nil NAD 
  
  
96 
 
OP. No: 2961 
OP. No: 13375 , Balasubramanian 41 / M  
P. o: 1559 , Rajeswari 23 / F 3375 , Balasubramanian 41 / M  
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OP. No: 126365 
OP. No: 126365 OP. No: 1559 , Rajeswari 23 / F 
OP. No: 1559 , Rajeswari 23 / F 
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DISCUSSION 
  Kapha peenisam is a disease characterised by headache, nasal block, 
sneezing, lacrimation, ear dishcarge, nasal itching, running nose and absence of 
taste. The signs and symptoms of kabha peenisam as per yugi can be correlated 
with sinusitis in modern science. 
  The aim of the study is to evaluate the therapeutic efficacy of the siddha 
formulation PERUNJCHIRAKA CHOORANAM in the treatment of kapha 
peenisam. 
  According to siddha system of medicine the causes of peenisam are 
exposure to cold atmosphere, drinking and taking bath in cold water. Regarding 
the etiology of sinusitis in modern medicine, it’s due to hypersensitivity to a 
variety of allergens, temperature variations, emotional factors, environmental 
pollution and lowered resistance. 
  For the clinical study 20 patients were selected and admitted as In 
patients in post graduate department of Pothu maruthuvam. They were treated 
with the trial medicine. 
  In the outpatient department of pothu maruthuvam 20 patients were 
selected and treated with the trial drug. The results were clearly observed and 
recorded under the supervision of professor, Reader and lecturers. The 
observations are disucssed below 
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Distribution of cases by Gender 
  The prevalence of the disease was found to be higher in females 
(23cases, 57.5%) among 40 patients 
Distribution of cases by age 
  The study showed that the highest incidence of kabha peenisam was 
between  51 – 60 years of age  (22 cases, 55%). 
Distribution of cases by kaalam (life span) 
  Out of 40 cases, 27.5 % (11 cases) were found to be in Vatha kaalam 
(upto 33 years) and 72.5 %  (29 Cases). 
Chronicity of diseases 
  Among 40 cases, 32.5% of cases had the duration upto 1 month and 
25% of cases had the duration of disease  for  2 – 6 months and 17.5% of cases 
had the duration of disease for 6 – 12 months.  5% of cases had the duration of 
disease  above 18 months.  
  The data illustrated the highest incidence of duration of disease among 
40 cases were within 1 months and for 2 – 6 months. 
 Distribution by Religion: 
  Among 40 cases 82.5% (33 cases) were Hindus, 7.5% (3 cases) were 
christians and 10% (4 cases) were muslims. 
Distribution of cases by Gunam 
  Most of the patients under this analysis were predominantly of Rajo 
gunam assessed from interrogation and other observations (40 cases). 
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Distribution of cases as per Thinai (Land) 
  Out of 40 cases, 85% (344 cases) were from Marutha Nilam,  7.5%   (3 
cases) were from Neithal nilam and 7.5% (3 case were from Mullai Nilam) 
Distribution of cases by paruva kaalam 
  Among 40 patients the occurence of the disease in Pinpanikaalam  15% 
(6 cases) and in Munpani Kaalam 25% (10 cases) and in Elavenil Kaalam  
37.5% (15 cases), 10% (4 cases)  Muthuvenil kaalam. As per siddha literature 
Munpanikaalam  and Pinpani kaalam are the periods of kabha peenisam. 
Distribution of cases by occupational status 
 Out of 40 cases, Housewives (10 cases) 25% were mostly affected, 10% 
(4 cases) were drivers and 15% (6 cases) were labour.   
 Chemical and dust exposure aggravates the disease. 
Distribution of cases by aetiological factor 
  Out of 40 patients majority of them were allerrgic to dust (27.5%) and 
cold exposure (55%). As per the literature, dusty environment is considered to 
be the main predisposing factor of Kabha peenisam. 
Distribution by socio economic status 
 Among 40 cases, 27.5% (11 cases) belonged to poor socio economic 
status, 62.5% (25 cases) belonged to middle class. 10% (4 cases) belonged to 
Rich. 
  This observation indicated the increased incidence of the disease in 
middle  socio economic status. 
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Distribution of cases by dietary habits 
  Out of 40 cases, 6 cases (15%) taking vegetarian diet and 36 cases  
(85%) taking Non vegetarian diet. 
Family history 
  Among 40 cases,  80% of the patients had negative family history. 20% 
of the patients had positive family history. 
  It is showed that most of the patients had negative family history. 
Clinical Manifestations 
  Out of 40 cases, 31 cases (77.5%) had clinical symptom of nasal 
congestion. 38 cases (95%) had sneezing, 24 cases  (65%) had headache, and 
18 cases  (45%) had facial pain and 18 cases (45%) had nasal discharge. 
Mode of onset 
  The observation illustrated that the mode of onset was 50% acute as well 
as 50% chronic. 
Derangements noted in Gnanendrium 
  Mooku was affected in 28 cases (70%) due to nasal block, running nose. 
Mei was affected in 12 cases (30% ) due to headacche and faccial pain and Kan 
was affected in 15 cases (37.5%) due to excessive lacrimatin, burning 
sensation. Sevi was affected in 4 cases (10%) due to otalgia. 
Derangements noted in kanmedrium 
  Kai was affected in 9 cases (22.5%), Kaal was affected in 7 cases 
(17.5%) due to pain in upper and lower limbs. 
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Derangements noted in Vatham 
  Out of 40 cases observed, Pranan was affected in 34 cases (85%) due to 
nasal block. Viyanan was  affected in  8 patients (20%) due to pain in lower 
limbs. Samanan was affected in 40 cases (100%) and uthanan was affected in 
27 cases (67.5%) of patients. Koorman was affected in 14 cases (35%) due to 
excessive lacrimation. Kirukaran was affected in 38 cases (95%) due to 
sneezing and Dhevathathan was affected in all 40 cases (100%) due to 
tiredness. 
Derangements noted in pitham 
  Analagam was affected in 12 cases (30%). Ranjagapitham was afffected 
in 8 patients (20%) due to pallor and Sathagapitham was affected in 26 patients  
(65%). 
Derangements noted in kabham 
  Avalambagam was affected in 40 patients (100%) of cases and 
Tharpagam was affected in 10 patients (25%) due to burning sensation of eyes 
and Sandhigam was affected in 14 patients (35%) 
Derangements noted in udal kattugal 
  Saram was affected in all cases (100%) Seneer was affected in 9 cases  
(22.5%) due to pallor. Kozhuppu was affected in 10 cases (25%) Enbu was 
affected in  7 cases (17.5%) 
Derangements noted in Envagai thervugal 
  Out of 40 cases observed, Vizhi was affected in 12 cases (30%) due to 
excessive lacrimation, Naa was affected in 8 cases (20%) due to pallor and 
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Mozhi was affected in 25 cases (62.5%) due to low pitched voice Sparisam was 
affected in 8 cases (20%). 
Distribution of cases by Naadi 
  Among 40 cases, 23 cases  (57.5%) had vatha pitha naadi and 11 cases  
(27.5%) had pitha kaba naadi and 4 cases (10%) had pitha vatham and 2 cases 
(5%) had kaba vatha naadi 
Distribution of cases by Neerkuri 
  Manam, Edai, Nurai and Enjal were not affected in all patients Niram 
was affected in  8 patients (20%) 
Distribution of caes by Neikuri 
  Among 40 patients, 21 patients (52.5%) had kaba neer and 9 patients  
(22.5%) had pitha neer, 5 patients (12.5%) had vatha neer and  5 patients 
(12.5%) had thontha neer. 
Radiological examination: 
  Among 40 cases, 18 patients (45%) had frontal sinusitis, 17 patients 
(42.5%) had left maxillary sinusitis, 10 patients (25%) had right maxillary 
sinusits, 2 patients (5%) had ethmoid sinusitis and 8 patients (20%) had 
deviated nasal septum. 
Outcome 
 After treatment with the trial medicine PERUNJCHIRAKA 
CHOORANAM (twice a day) for 30 days, 31 patients (77.5%) were relieved 
from sneezing, 10 patients (25%) were relieved from rhinitis, 22 patients (55%) 
were relieved from nasal congestion, 17 patients (42.5%) were relieved from 
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headache, 9 patients (22.5%) were relieved from lacrimation, 11 patients 
(27.5%) from facial pain, and 2 patients (5%) from otalgia. 
Blood parameter 
 Out of 40 patients, 9 patients (22.5%) had elevated absolute eosionphil 
count (AEC) before treatment. 
 After treatment AEC level was normal in 35 patients (87.5%) and in               
5 cases (12.5%) it was moderately reduced. 
Erythrocyte sedimentation rate 
 Out of 40 cases, 32 cases (80%), the ESR level was normal and in 8 
cases (20%) it was moderately reduced. 
Gradation of Results: 
  Among 40 cases,  85% (34 cases) showed good result and 15% (6 cases) 
showed moderate result. 
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SUMMARY 
 The aim of the study is to assess the therapeutic efficacy of trial drug 
‘PERUNJCHIRAKA CHOORANAM’ for ‘Kabha peenisam’ without 
any adverse effects. 
 The etiopathogenesis and symptoms of kabha peenisam have been 
correlated with that of sinusitis with evidence of literature. 
 Clinical diagnosis and selection of cases was based on clinical features 
described in siddha maruthuvam (Pothu) text book. 
 The ingredient of the drug PERUNJCHIRAKA CHOORANAM possess 
anti inflammatory, anti pyretic, antimicrobial and immunomodulator 
effect. 
 The medicine chosen for treatment and management of kabha peenisam 
was PERUNJCHIRAKA CHOORANAM 2gm internally, twice a day, 
after food. 
 The trial drug selection is based on its siddha pharmacological action to 
pacify the deranged vatham, pitham and kabam and also due to its anti-
inflammatory, antipyretic, antimicrobial and immunomodulator effect of 
ingredients. 
 40 patients (20 In-patients and 20 out-patients) were diagnosed with 
kabha peenisam clinically and they were observed for clinical diagnosis, 
laboratory diagnosis. 
 The documentation of observations made during the clinical study 
showed that the drug is clinically effctive. 
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 The Biochemical analysis the trial medicine had calcium, sulphate, 
chloride, starch, iron, amino acid and unstaturated compound which 
adds to the clinical prognosis of kabha peenisam by Perunjchiraka 
chooranam 
 Antimicrobial activities of PERUNJCHIRAKA CHOORANAM showed 
that it  inhibited the growth of bacterial strains against streptococcus 
preumoniae, staphylococcus aureus, Escherichia coli and Klebsiella 
pneumoniae. 
 In the pharmacological analysis, the trial drug PERUNJCHIRAKA 
CHOORANAM had significant anti inflammatory action. 
 Acute oral toxicity study 
Acute toxicity studies done in Periyar college of pharmaceutical 
sciences, Trichy for research as per OECD guidelines revealed the 
safety of the drug in oraldose it did not produce any adverse effects in 
animals at level of 2gm/kg body weight. 
 Result: 
All of the rats feed with the food sample showed normal general 
behaviour, respiraory pattern, cardiovascular signs, motor activities, 
relfexes and normal change in skin and fur. 
 Haematological parameter, biochemical, urine parameter, histo 
pathological examination did not show any abnormal variation. 
With these benefits PERUNJCHIRAKA CHOORANAM can be 
deemed as an effective drug for kabha peenisam (sinusitis). 
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CONCLUSION 
From the present study, 
 The preparation and administration of the drug is safe, affertable and 
highly efficacious and more acceptable. 
 The cost of trial medicine is comparatively very low. 
 The medicine has many properties to control the signs and symptoms of 
kabha peenisam. 
 No adverse effects were noticed during the course of treatment. 
 Toxicity study reveals that the trial drug is safe even in higher dose of 
2gm/kg body weight in wistar albino rats as per OECD guidelines. 
Therefore, it is concluded that the trial drug ‘PERUNJCHIRAKA 
CHOORANAM’ can be used for the management of Kabha peenisam. 
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ANNEXURE – I 
PROPERTIES OF TRIAL DRUG 
INTERNAL MEDICINE-PERUNJCHIRAKA CHOORANAM  
DRUG INGREDIENT 
1. ohVR<sQvgl<< Q << Q << Q <!
BOTANICAL NAME  : Pimpinella anisum (Apiaceae) 
SYNONYMS   : Sombu, Venseeragam 
ENGLISH NAME  : Anise – seeds, Anise fruit 
PART USED   : Fruit. 
Suvai : Kaarpu, Sweet 
Thanmai : Hot 
Pirivu : Kaarpu 
  Action 
 Fruit  or seed is stimulant 
 Carminative 
 Diuretic 
 Expectorant and the fruit and oild are Aromatic stomachic and 
carminative, oil is stimulant, Expectorant like all volatile 
Diaphoretic and mild expectorant 
 
ohiKg<G{l<< << << <!
! “ObieqOfib<!Ge<ll<!d'm<jslf<!kl<ohiVlz<< < < < < < << < < < < < << < < < < < <!
OheLX!gisl<!hQzqslqjvh<!< Q << Q << Q < .!hQedjvQQQ !
Osi<g<gqe<x!uikLOhiR<!sQi<ohiqb!sQvgk<kiz<< < < < Q < Q < << < < < Q < Q < << < < < Q < Q < <!
&g<GOfi!bqz<jz!olipq< << << < ”!
! ! ! ! ! .!ngk<<<<kqbi<!G{uigml<< << << <!
Constituents 
 Fruit yields and essential oil which is known as the oil of anise 
seeds and consists of  anethole or anise camphor, anise aldehyde 
and methychavicol 
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Therapeutic uses 
 Uterus disorder, colic, fever indigestion, cough, liver disorder, sneezing, 
sore throat and cold 
 This also cures flatulence in uterus. This acts as galactagogue. 
Decoction of the seeds is used to releive uterous disorders  
 Powdered seeds give relief in stomachache, flatulence, fever and cough  
 Oil extracted from the seeds if taken internally induces heat and cures 
dyspepsia, This oil eradicate intestinal colic. 
 
PREPARATION OF TRIAL DRUG 
Purification : 
 Remove the dust particles and stored with container 
Method of Preparation: 
 The above prufied raw drug slightly roasted then powdered (chooranam) 
and stored with air tight container. Filtered with pure white cloth 
(Vasthirakayam). 
   - Ref: Gunapadam Mooligai Vaguppu Pg.no. 467, 468 
Dosage: 
  2gm BD 
Adjuvant: 
  Water 
Indication: 
 Mukku noi (Peenisam) 
Expiry:  
  3 Months from the date of preparation 
Reference: 
  Gunapadam Mooligai Vaguppu Pg.no. 467, 468 
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ANNEXURE - II 
BIO-CHEMICAL ANALYSIS 
BIO-CHEMICAL ANALYSIS OF PERUNJCHIRAKA CHOORANAM 
Preparation of the extract:   
  5gms of the drug was weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water is added and dissolved well.  Then it is 
boiled well for about 10 minutes.  It is cooled and filtered in a 100ml 
volumetric flask and then it is make up to 100ml with distilled water.  This 
fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube. To this add 
2ml of 4% Ammonium oxalate 
solution 
A white precipitate 
is formed 
Indicates the 
Presence of 
calcium 
2. TEST FOR SULPHATE 
2ml of the extract is added to 5% 
Barium chloride solution. 
A white precipitate 
is formed 
Indicates the 
presence of 
sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
A white precipitate 
is formed 
Indicates the 
presence  of 
chloride 
4. TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
 
No Brisk 
effervessence is 
formed 
Absence of 
carbonate 
5. TEST FOR STARCH 
The extract is added with weak iodine 
solution 
 
Blue colour is 
formed 
Indicates the 
presence of 
starch 
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6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro 
cyanide. 
 No blue colour is 
formed 
Absence of 
ferric iron 
7. TEST OF FERROUS IRON  
The extract is treated with 
concentrated Nitric acid and 
Ammonium thio cyanate solution 
Blood red colour is 
formed 
Indicates the 
presence of 
ferrous iron 
8.  TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric 
acid 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
9.  TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is 
formed 
Absence of 
Albumin 
10.  TEST FOR TANNIC ACID 
The extract is treated with ferric 
chloride. 
No Blue black 
precipitate is 
formed 
Absence of 
tannic acid 
11.  TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets  
decolourised 
 
Indicates the 
presence of 
unsaturated 
compound 
12.  TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 mts and add 8-10 drops of 
the extract and again boil it for 2 mts. 
 
 
No colour change 
occurs. 
Absence of 
Reducing sugar 
  
114 
13.  TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried well. 
After drying, 1% Ninnhydrin is 
sprayed over the same and dried it 
well. 
 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
14. TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
Zinc. 
 
Inference: 
  The extract prepared from the given sample Perunjchiraka chooranam 
contains calcium, sulphate, chloride, starch, iron, amino acid, unsaturated compound. 
Biochemical Analysis report was given by  Mrs. N.Nagaprema, M.Sc., H.O.D,              
Bio Chemical Department, Government Siddha Medical College, Palayamkottai. 
 
  
115 
ANNEXURE - III 
ANTI – MICROBIAL STUDY OF PERUNJCHIRAKA CHOORANAM 
BY KIRBY – BAUER METHED 
AIM 
 To determine the Antimicrobial activity of PERUNJCHIRAKA 
CHOORANAM. 
COMPONENTS OF MULLER HINTON AGAR MEDIUM: 
Beef Extract   : 300 gms/lit 
Agar    : 17 gms/lit 
Starch    : 1.5 gms/lit 
Casein hydroxylate  : 17.5 gms/lit 
Distilled water  : 1000 ml 
PH    : 7.6 
PROCEDURE 
 The method of antimicrobial activity study is by Diffusion Method. 
 Antibiotic discs are prepared with known concentration of antibiotic are 
placed on agar plates that has been inoculated with the known pathogenic 
Micro organism. The antibiotic diffuses through the agar producing an 
antibiotic concentration. Gradient antimicrobial susceptibility is proportional to 
the diameter of the inhibitory zone around the disc. If the micro organism 
which grows upto the edge of the disc are resistant to the anti microbial agent. 
 The recommended medium in this method is Muller Hinton Agar; its PH 
should be between 7.2 – 7.6 and should be poured to uniform thickness of 4mm 
in the petri plate (25ml) 
Methodology: 
 Muller Hinton Agar plates are prepared and Streptococcus pneumonia, 
Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae are inoculated 
separately. 
 The prepared discs of PERUNJCHIRAKA CHOORANAM are placed 
over the incubated plate using sterile forceps and incubated for 24 hours at 37° 
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celcius. The plates after 24 hours incubation are observed for the zone of 
inhibition. 
 
Result: 
                      Zone size  
S.NO 
 
Test Drug 
 
 
Organism 
(culture) 
Control 
(mm) 
Test  
(mm) Susceptibility 
1.  
 
2. 
 
 
 
3. 
 
 
4. 
 
 
 
 
 
PERUNJCHIRAKA 
CHOORANAM 
 
 
 
 
 
 
               
Streptococcus 
pneumoniae 
 
Staphylococcus 
aureus 
 
                                             
Escerichia coli 
                               
           
Klebsiella 
pneumoniae 
 
14 
 
 
20 
 
 
20 
 
    
20 
13 
 
 
17 
 
 
17 
 
 
19 
Moderate 
sensitive 
 
Sensitive 
 
 
Sensitive 
 
 
Sensitive 
 
RESULT 
  PERUNJCHIRAKA CHOORANAM is Sensitive to Staphylococcus 
aureus, E coli, Klebsiella  pneumoniae and  Moderately sensitive to 
Streptococcus pneumoniae. 
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ANNEXURE - IV 
PHARMACOLOGICAL STUDY FOR PERUNJCHIRAKA 
CHOORANAM 
 
ACUTE TOXICITY STUDY 
 
  Acute oral toxicity refers to those adverse effects occurring following oral 
administration of a single dose of a single dose of a substance or multiple doses 
given within 24 hours. Acute toxic class method (OECD guidelines 423, (2000) was 
followed to arrive at the maximum safety dose of the drug extracts. Three Wistar strain 
female albino rats (8-12 weeks old, 180-200g body weight) were used in each group. 
Single dose (2g/kg) of the Perunjchiraka chooranam was orally administered to 
overnight fasted (food but not water withheld) animas while control animals 
received the vehicle (0.3%w/v CMC). Animals were observed individually after 
dosing at least once during the first 4 hrs and daily thereafter, for a total of 14days. 
Body weights of the animals were recorded. The other observations include changes 
for skin, fur, eyes and mucous membranes, respiratory, circulatory and autonomic and 
central nervous system and somatomotor activity and behavior pattern. At the end 
of 14 days, all animals were subjected to gross necropsy 
 
Statistics 
  Data are expressed as mean ± SEM; data analysed by one way ANOVA 
followed by Dunnet's multiple range tests to determine the significance of the 
difference between the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.5. 
 
Results 
Acute toxicity study 
  All of the rats fed with the food sample showed normal general behavior, 
respiratory pattern, cardiovascular signs, motor activities, reflexes and normal change 
in skin and fur. 
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Table - 2 Hematological values of Per unjchiraka chooranam in the acute toxicity 
study 
 
S.No Parameter Control Sample 2g/kg 
1 White blood cells (xlOV) 9.36±0.54 9.14 ±0.93 
2 Hemoglobin (g/dl) 11.50±0.26 12.57 ±1.42 
3 Mean corpuscular volume 60.45±2.3 59.34 ±0.34 
4 Mean corpuscular hemoglobin cone, 
(g/dl) 
34.56±0.86 30.21± 1.39 
5 Platelet (xlOVul) 5.60±0.52 4.98 ±0.60 
6 Red blood cell (xlOV) 3.87±0.24 2.98 ±0.58 
Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
 
Table - 3 
Blood chemical values of food sample in the acute toxicity study 
S.No Parameter Control Sample 2g/kg 
1 Glucose (mg/dl) 148.75±3.96 143.83±2.01 
2 BUN(mg/dl) 34.26±1.23 40.09±0.21 
3 Creatinine(mg/dl) 0.46±0.06 0.36±0.14 
4 Total protein (g/dl) 5.48±0.23 4.98±1.25 
5 Albumin (g/dl) 3.49±0.62 3.62±0.19 
6 Total bilirubin (mg/dl) 0.26±0.02 0.39±0.10 
7 AST (u/1) 141.5±3.76 138.25±2.43 
8 ALT (u/1) 86.36±1.75 78.37± 0.25 
9 ALP (u/1) 75.57±2.16 71.06±0.26 
Values are expresses as Mean ± S.E.M. 
All groups were treated with oral dose of 2g/kg body weight 
No significant different from normal control 
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DISCUSSION AND CONCLUSION 
  In acute toxicity study for 14 days, at a dose of 2g/kg of Perunjchiraka 
chooranam sample were chosen for the experiment. In the aspect of general 
behaviours, the rats treated with food sample at a single dose had no signs of 
behavior changes and toxic signs. The treated groups revealed no significant 
differences in body weight gain. The increase in body weight may have resulted from 
physiological changes in rats such as metabolism, food and water intake. However, 
the result from animal health monitoring in the entire period of 14days showed no sign 
of morbidity and diseases. 
  The albino Wistar rats were healthy as shown by the normal appearance of 
general behavior, respiratory pattern, cardiovascular signs, motor activities, reflexes 
and normal change, in skin fur. 
  With regards to hematological values, most of values in treated groups were 
normal in comparison with the control group. Significantly, some values were 
different from those of the control group such as RBC, MCV, MCHC, and platelet. 
However, such values are within the normal ranges. These variations may have 
resulted from variation among animal groups (Feldman et al., 2000) (Inala et al., 
2002). Therefore, these results suggest that the test drug did not cause hematological 
or immunological defects in rats. 
  Furthermore, blood chemical examination was performed in order to evaluate 
any toxic effects on liver. In this study, the levels of these blood chemical values were 
minor changes and remained within the normal range (Casley and King, 1980) 
(Levine, 1995) (Angkhasirisap et al., 2002). 
In conclusion, Perunjchiraka chooranam sample given orally to Wistar rats did not 
produce toxicities. 
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ANTI-INFLAMMATORY ACTIVITY 
Anti-inflammatory activity of Perunjchiraka chooranam against Carrageenan 
induced pawedema in rats 
  The anti-inflammatory activities of Perunjchiraka chooranam at a dose of 
lOOmg/kg and 200mg/kg body weight were evaluated using Carrageenan induced 
paw edema method. The inflammation was readily produced in the form of edema 
with the help of the irritant such as carrageenan. Carrageenan is a sulphated 
polysaccharide obtained from sea weed (Rhodophyceae) and when injected cause the 
release of prostaglandins by the way it produces inflammation and edema. 
Requirements 
Animal: Albino rat (180 - 200g) 
Drugs and chemicals: Diclofenac sodium (standard), 
carrageenan (1%), Perunjchiraka chooranam 
Digital plethysmometer UGO Basile (Italy) Method 
  The animals were divided into 4 groups each having six animals Treatment 
protocol 
Group-1: Treated as normal control received lOml/kg of normal saline through orally 
Group- 2: Treated as standard control received lOmg/kg of diclofenac sodium through 
orally 
Group- 3: Treated as treatment control received lOOmg/kg of Perunjchiraka 
chooranam with 2 ml of sterile water through orally 
Group- 4: Treated as treatment control received 200mg/kg of Perunjchiraka 
chooranam with 2 ml of sterile water administered through orally 
  A freshly prepared suspension of carrageenan (1% w/v, 0.1ml) was injected to 
the plantar region of left hind paw of each rat. One group was kept as control and the 
animals of the other groups were pretreated with Perunjchiraka chooranam given 
through orally 60 min before the carrageenan treatment. The paw volumes of the test 
compounds, standard and control groups were measured at 60, 120, 180 minutes of 
carrageenan treatment with the help of Digital plethysmometer UGO Basile (Italy). 
Mean increase in paw volume was measured and the percentage of inhibition was 
calculated. 
% anti-inflammatory activity = (Vc - Vt/Vc) x 100 
Where Vt is mean increase in paw volume in rats treated with test compounds 
Vc is mean increase in paw volume in control group of rats 
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Statistics 
  Data are expressed as mean ± SEM; data analysed by one way ANOVA 
followed by Dunnet's multiple range tests to determine the significance of the 
difference between the control group and rats treated with test compounds. 
* Values were considered significant at P < 0.01. 
 
ANTI - INFLAMMATORY ACTIVITY 
Anti-inflammatory activity of Perunjchiraka chooranam against Carrageenan 
induced paw edema in rats 
 
Treatment Dose (mg/kg) Paw volume(ml) 
as measured at 3 
Percentage 
inhibition of paw 
Group I Normal saline 5 ml/kg orally 4.95 ± 0.76  
Group II Standard lOmg/kg Diclofenac 
sodium through orally 
1.31 ±0.05 59.05** 
Group III Perunjchiraka 
chooranam 
lOOmg/kg administered 
through orally 
2.95 ± 0.35 51.38** 
Group IV Perunjchiraka 
chooranam 
200mg/kg administered 
through orally 
2.95 ± 0.50 58.10** 
Values are expressed as mean ± SEM 
Values are analyzed by one way AN OVA followed by Dunnet's multiple range 
tests, to determine the significance of the difference between the control group and 
rats treated with the test compounds. 
** Values were considered significant at P < 0.01.  
Results 
  Perunjchiraka chooranam at a dose of 100 and 200mg/kg were tested 
for their anti-inflammatory activity by using carrageenan induced rat paw edema 
method and the results are tabulated in table. The results reveals that both doses of 
Perunjchiraka chooranam 100 and 200mg/kg possess significant anti-inflammatory 
activity when compared to control group at p<0.01. 
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ANTIPYRETIC ACTIVITY 
  Male rat weighing 200-250g were injected subcutaneously aqueous 
suspension of dried brewer's yeast (12%, lml/lOOg body weight). Rats developing 
1°C or more rise in rectal temperature 18h after injection were treated with 5% 
gum acacia p.o. and served as control groupl. Group 2&3 received the 
Perunjchiraka chooranam (lOOmg/kg & 200mg/kg) respectively. Group 4 was 
treated with paracetamol (25mg/kg) which served as the standard reference drug. 
Temperature was recorded at time intervals of 1, 2, 3 and 4 hours. The decrease in 
the rectal temperature when compared with the control is taken as the index of 
antipyretic activity. 
Effect of Perunjchiraka chooranam on Brewer's yeast induced pyrexia in rats 
 
s. Treatment Dose Normal Temperature Temperature after treatment with 
No   Temperatu 18hrs      after  extract (°C)  
   re°C yeast induced lh 2h 3h 4h    ' 
    pyrexia     
1 Control — 37.2        ± 39.0 39.2 39.2 39.6 39.4* 
   0.04 ± ± ± ± ± 
    0.02 0.04 0.05 0.05 0.05 
2 Perunjchiraka lOOmg/kg 37.3        ± 38.6 38.0 38.4 38.1 38.0* 
 chooranam  0.08 ± ± ± ± ± 
    0.08 0.16 0.05 0.11 0.08 
3 Perunjchiraka 200mg/kg 37.2        ± 39.2 38.6 39.4 38.0 37.8* 
 chooranam  0.07 ± ± ± ± ± 
    0.12 0.19 0.07 0.07 0.11 
4 Paracetamol 25mg/kg 37.6       ± 39.4 38.2 37.4 38.0 37.7* 
   0.24 ± ± ± ± ± 
    0.06 0.4 0..28 0.11 0.17 
N=6 values are mean±S.E. 
*p<0.01 Vs Control 
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ANNEXURE - V 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, 
TIRUNELVELI 
DEPARTMENT OF MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON “KABHA PEENISAM” 
(SINUSITIS) AND THE DRUG OF  CHOICE  IS “PERUNJCHIRAKA 
CHOORANAM ” (internal) 
  FORM I SCREENING & SELECTION PROFORMA 
                                                                                      REG NO: 321211003 /2014-15 
 
1. STUDY  NO______                                         2 OP /IP NO:__________ 
 
3.NAME :______________________________ 4. AGE/SEX________                                 
 
5.RELIGION  : H / C / M / O             6.OCCUPATION / INCOME : __________ 
 
 INCLUSION CRITERIA 
∗ Age 18 to 60yrs         
∗ Sex :Male/FEMALE 
∗ Facial pain, purulent nasal discharge, nasal block, headache/heaviness of head, 
sneezing, fever, tooth pain, if any one or two symptoms.                                                           
Yes/No 
∗ Patient willing to undergo lab investigations    Yes/No 
∗ Patient willingness for consent to include in the trial                                       
Yes/No 
∗ Patient willingness for radiological investigation(x ray of para nasal sinuses). 
 
EXCLUSION CRITERIA 
• Bronchial asthma,  
• Tuberculosis, 
• Heart disease, 
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• Epistaxis 
• Fracture and tumour of nose 
• Tuberculosis 
• Hypothyroidism 
• Paediatric patient less than 13 years 
• Patient with anyother severe illness 
• Chronic obstructive pulmonary disease, 
• Renal disease. 
 
ADMITTED TO TRAIL:    YES         NO         If Yes Serial NO:  
 
Date: 
Station: 
                                                                                     
Signature of  the Investigator:                                                        
 
Signature of the Lecturer:      
         
        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
 
DEPARTMENT OF POTHU MARUTHUVAM    
 
PRECLINICAL AND   CLINICAL STUDY ON KABHAPEENISAM 
(SINUSITIS) WITH PERUNJCHIRAKA CHOORANAM 
 
FORM II 
    
HISTORY PROFORMA ON ENROLLMENT 
 
 
1. S.No :   _______________                 2. OP/IP No:_______________ 
 
       
3. Name: ________________               4. Gender:   Male                        Female    
 
 
5. Age (years): _________   DOB            
 
      Date       Month            Year 
 
6. Address: -------------------------------------- 
                     -------------------------------------- 
                     -------------------------------------- 
 
7. A. Occupation:    -----------------------------            B. Nature of work----------------- 
 
8. Educational Status:   A) Illiterate                  B) Literate          
 
9. Height: --------- cms                10.Weight:----------kg 
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11. Complaints and Duration:   
 
 
12. History of past illness: 
 
 
13. Habit of 
 
A) Smoking :     1. Yes                duration ___years;    Number - _____             2. No  
 
Past H/O chronic smoking: 
 
B) Alcoholism:   1. Yes               duration ____ years;      Quantity- ____ ml     2. No  
 
C) Tobacco chewing:  1. Yes                  duration ___years                                 2.No 
                                     
D) Betel chewing     :  1. Yes                 duration ________ years                       2.No 
 
 
14. Diet:  A.Pure vegetarian                                    B.Non-vegetarian                 
 
15. Drug history: Had the patient been treated before with allopathy drug?  
 
                                1. Yes                            2. No                                     
 
16. Marital status:  1.Married         2.Unmarried                                                  
 
17. Family history: 
 
      Whether this problem runs in family?             1. Yes                               2.No   
  
If yes, mention the relationship of affected person(s)___________________________                                                                                                              
                                        
18. Menstrual history:  ......................    
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19. Bowel habits & micturition:      Normal                         Abnormal 
 
20. Psychological state:      Normal                  Anxiety                         Depression             
 
 
 
  Date      :   
   
  Station    : 
 
  Signature of Investigator 
 
 
 
  Signature of Reader/Lecturer                                            Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL,                                                                               
TIRUNELVELI 
DEPARTMENT OF POTHU MARUTHUVAM 
FORM - III 
PRE CLINICAL AND CLINICAL STUDY ON “KABHA PEENISAM” 
(SINUSITIS) AND THE DRUG OF CHOICE IS “PERUNJCHIRAKA 
CHOORANAM” (internal) 
       
1. STUDY  NO  
2. OP/IP NO      REG NO: 321211003 /2014-15 
3.NAME                                                                                                                             
4.GENDER / MALE /FEMALE 
5. DATE OF ASSESSMENT    
  Initial (0th day)           7th day           13th  day         19th day          25th day 
 
 
SIDDHA SYSTEM OF EXAMINATION 
ENNVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
     
 
  
 
Naadi 0th 
day 
7th 
day 
13th 
day 
19th 
day 
25th 
day 
Naadi 0th 
day 
7th 
day 
13th 
day 
19th 
day 
25th 
day 
Vali      Iyya vali      
Azhal      Vali 
Iyyam 
     
Iyyam      Azhal 
Iyyam 
     
Vali 
azhal 
     Iyya 
Azhal 
     
Azhal 
vali 
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I. NAA: [TONGUE] 
 
 
 
0th Day 7th Day 12th Day 19th Day 25th Day 
Colour Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Dark / 
Yellow/ 
Red / Pale/ 
Normal 
 
Taste Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Sweet/ 
Bitter / 
Sour 
Pungent/ 
None 
Coating Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Fissure Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Saliva Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Normal/ 
Increased/ 
Decreased 
Dryness Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Glossitis Present/ 
Absent 
Present 
/Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Baldnes
s 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
III.NIRAM: [COMPLEXION]    
 
0th Day 7th day 13th Day 19th Day 25nd Day 
Dark/ 
Yellowtinted/ 
Wheatish 
brown/ Pale 
Dark/ 
Yellowtinted/ 
Wheatish 
brown/ Pale 
Dark/ 
Yellowtinted/ 
Wheatish 
brown/ Pale 
Dark/ 
Yellowtinted/ 
Wheatish 
brown/ Pale 
Dark/ 
Yellowtinted/ 
Wheatish 
brown/ Pale 
 
IV.MOZHI: [VOICE] 
 
0th Day 7th day 13th Day 19th Day 25nd Day 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Low pitched 
Medium/ 
High/ 
Lowpitched 
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V.VIZHI: [EYES] (Lower palpabrel conjunctiva)   
 
0th Day 7th day 13th Day 19th Day 25nd Day 
Yellow 
Red 
/ Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
Yellow 
Red/ 
Pale/Normal 
   
VI. MALAM; [BOWEL HABITS / STOOLS] 
 
 0th Day 7th Day 13 th Day 19nd Day 25th day 
Colour Dark/ 
Yellow/ 
Pale/Others 
Dark/ 
Yellow/ 
Pale/Others 
Dark/  
Yellow 
Pale/Others 
Dark/ 
Yellow/ 
Pale/Others 
Dark/  
Yellow/ 
Pale/Others 
Consistency Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Solid/ 
Semisolid 
Watery 
Stool  bulk                         Normal/ 
Reduced 
Normal 
/Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Normal/ 
Reduced 
Constipation  Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Diarrhoea Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
 
VII. URINE EXAMINATION:  
NEER 
KURI 
0th Day 7th Day 13 th Day 19nd Day 25 th day 
Niram 
[Colour]   White/ Yellowish/ 
Straw 
coloured/ 
Crystal 
clear 
White/ 
Yellowish/ 
Straw 
coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw 
coloured/ 
Crystal clear 
White/ 
Yellowish/ 
Straw 
coloured/ 
Crystal clear 
White/ 
Yellowish
/ 
Straw 
coloured/ 
Crystal 
clear 
Manam 
[Odour] 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Present/ 
Absent 
Nurai 
[Froth] 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Nil/ 
Reduced/ 
Increased 
Edai 
[Sp.gra]                               
Normal/ 
Increased/
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Enjal 
[Deposits] 
Present/ 
 Absent 
Present/ 
 Absent 
Present/ 
 Absent 
Present/ 
 Absent 
Present/ 
 Absent 
Volume   Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
Normal/ 
Increased/ 
Reduced 
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VIII. SPARISAM: [PALPATORY  PERCEPTION] 
 
2.THEGI: [ TYPE OF BODY CONSTITUTION]  
   
Vatham predominant  Kabam predominant  
Pitham predominant  Thondha udal  
 
3.NILAM: [ LAND WHERE PATIENT LIVED MOST] 
 
 
  Kurinji               Mullai                 Marutham             Neithal              Palai 
 
 (Hilly terrain)      (Plains)                (Coastal belt)        (Aridregions)    (Forestrange) 
 
 
NEIKURI 0th day 7th day 13th day 19th day 25th day 
Serpentine fashion      
Annular/Ringed 
fashion 
     
Pearl beaded fashion         
Mixed fashion      
Other fashion      
0th Day 7th Day 13th Day 19th Day 25nd Day 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
Warmth/ 
Cold/ 
Normal/ 
Sweat 
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4.KAALAM 
 
Kaarkalam   Pinpanikalam      
Koothirkalam   Ilavenil 
Munpanikalam   Muthuvenil 
 
5. GUNAM 
Sathuvam                        Rasatham                       Thamasam 
 
6.,IMPORIGAL (SENSORY ORGANS) 
 
 
7.KANMENTHIRIYAM ( MOTOR ORGANS) 
 
 0th day 7th day 13th day 19th day 25th day 
Mei  
(Skin) 
     
Vaai 
(Buccal 
Cavity) 
     
 
Kann 
 (Eye) 
     
 
Mooku 
(Nose) 
     
 
Sevi(Ear) 
     
Kanmenthiriyam  0th day 7th day 13th day 19th day 25th day 
Kai (upper limb)      
Kaal (lower limbs )      
Vaai   (buccal cavity)      
Eruvai (excretory 
organs) 
     
Karuvai  
(reproductive organs) 
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8..KOSANGAL(Sheath)   
 
Kosangal 
 
0th day 7th day 13th day 19th day 25th day 
Annamaya Kosam 
 
     
Pranamaya kosam      
Manomaya kosam       
Vignanamaya kosam  
 
     
Ananthamaya kosam      
 
9. MUKKUTRAM:[AFFECTION OF THREE HUMORS] 
A)VATHAM: 
 
Vatham  0th day 7th day 13th day 19th day 25th day 
Praanan      
Abaanan      
Samaanan      
Udhaanan      
Viyaanan      
Naagan      
Koorman      
Kirukaran      
Devathathan      
Dhananjeyan      
 
B) PITHAM: 
Pitham 0th day 7th day 13th day 19th day 25th day 
Analapitham      
Prasakam      
Ranjakam      
Aalosakam      
Saathakam      
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C) KABAM: 
 
Kabam  0th day 7th day 13th day 19th day 25th day 
Avalambagam      
Kilethagam      
Pothagam      
Tharpagam       
Santhigam      
 
10. SEVEN DHATHUS: (7 SOMATIC COMPONENTS)  
 
Udal thathukkal  0th day 7th day 13th day 19th day 25th day 
Saaram[Chyme]      
Senneer[Blood]       
Oon[Muscle]      
Kozhuppu[Fat]      
Enbu[Bones]      
Moolai 
[Bonemarrow] 
     
Sukkilam/Suronith
am[Genital 
discharges] 
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11. SYSTEMIC EXAMINATION: 
 
 
12. GENERAL EXAMINATION: 
 
General Examination: 
 
0th day 7th day 13th day 19th day 25th day 
Height (cms)      
Weight (kg)      
Temperature(°F)         
Pulse rate (per min)      
Heart rate (per min)      
Respiratoryrate(per min)      
Blood pressure(mm/Hg)      
Pallor      
Jaundice      
Cyanosis      
Lymphadenopathy      
Pedal edema      
Clubbing      
Jugular venous pulsation      
 
Systemic examination 0th  
day 
7th 
 day 
13th  
day 
19th 
 day 
25th day 
Locomotor system      
Cardio Vascular System  
 
    
Respiratory system       
 
    
Gastro Intestinal system     
 
    
Central Nervous System        
 
    
Urogenital system      
Endocrine System      
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13. CLINICAL SYMPTOMS 
 
 
              
 
  
Date : 
 
Station: 
 
 
Signature of the Investigator: 
 
  
 
Signature of the Lecturer:     
 
 
     Signature of the HOD 
 
 
 
 
 
S.no CLINICAL 
SYMPTOMS 
0 th 
day 
7th day 13th 
day 
19th 
day 
25th 
day 
1 Nasal purulent      
2 Headache/Heaviness of head      
3 Facial pain       
4 Nasal block      
5 Sneezing      
6 Tooth ache      
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT. 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND  CLINICAL TRIAL ON  
KABHAPEENISAM (SINUSITS) WITH                    
PERUNJCHIRAKA CHOORANAM 
 
FORM IV 
 
LABORATORY PARAMETERS – CHART 
 
1. S.No : ____________________           2. OPD/ IPD No : 
____________________ 
3. Bed No  : ____________________ 4. Name  : ____________________ 
5. Age  : __________ Years             5. Gender :    Male -                    Female – 
 
INVESTIGATIONS: 
I.BLOOD 
S.No  NORMAL VALUES BEFORE 
TREATMENT 
AFTER 
TREATMENT 
1. TC (million/                                              
cu.mm) 
Male     - 4.30 – 5.60
Female  - 4.00 – 5.20 
  
2.  DC  3.54 – 9.06 ×10³ /mm³   
 Neutrophils 40 – 70%   
 Lymphocytes 20 – 50%   
 Monocytes  4 – 8 %   
 Eosinophils  0 – 6 %   
 Basophils  0 – 2%   
3. ESR Male    – 0 – 15 mm/hr 
Female – 0 – 20 mm/hr 
  
      ½hr    
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      1 hr    
4. Haemoglobin Male    - 13.3 – 16.2 g/dL 
Female – 12.0 – 15.8 g/Dl 
  
5. Blood sugar 
(F/R/PP) 
Fasting – 75 – 110mg/dL 
Random – 80 – 170mg/dL 
  
6.  Blood urea 20 – 40 mg/Dl   
7. Serum 
creatinine 
Male    - 0.6 – 1.2 ng/mL 
Female – 0.5 – 0.9 ng/mL 
  
8. Serum 
cholesterol 
< 200         Desirable 
200 – 239  Borderline high 
≥ 240         High 
  
 
II. URINE: 
Albumin  - 
Sugar    - 
Deposits  - 
 
III. RADIOLOGICAL INVESTIGATION: 
 Skull  X  ray –PNS view 
 
Date       : 
Station    :        
 Signature of Investigator                                                    Signature of the HOD 
          
                      
 Signature of Reader/ Lecturer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRE CLINICAL AND CLINICAL TRIAL ON 
KABHAPEENISAM (SINUSITIS) WITH 
PERUNJCHIRAKA CHOORANAM 
FORM V 
CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
Date...................      signature...................... 
Name................................................ 
CONSENT BY PATIENT 
I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial and the nature of drug treatment and follow-up including 
the laboratory investigations to be performed to monitor and safe guard my body 
functions. 
I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
I exercising my free power of choice, hereby give my consent to be included. 
As a subject in the clinical trial of PERUNJCHIRAKA CHOORANAM of 
KABHAPEENISAM (sinusitis). 
Date........................      signature.............. 
Place......................      name............................. 
Signature of witness.............................     
Name.................................................... 
Relationship.........................................     
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  GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND  CLINICAL STUDY ON 
KABHAPEENISAM (SINUSITIS) WITH 
PERUNJCHIRAKA CHOORANAM 
 
FORM VI 
WITHDRAWAL FORM 
 
Name: ________________________       OPD/ IPD number: __________ 
Age   : ________                                       Sex : ______________ 
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Reasons for withdrawal: 
• Long absence at reporting       :   Yes                  No 
• Irregular treatment        :  Yes                   No 
• Shift of locality                                                   :    Yes                 No          
• Increase in severity of symptoms                 :    Yes                  No 
• Development of severe adverse drug reactions  :    Yes                  No 
 Date    :      
Station :     
Signature of Investigator                   Signature of the HOD          
                      
 
 
Signature of Reader/ Lecturer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
PRE CLINICAL AND CLINICAL TRIAL ON 
KABHAPEENISAM (SINUSITIS) WITH 
PERUNJCHIRAKA CHOORANAM 
FORM VII 
PATIENT INFORMATION SHEET 
 
• Sinusitis is the inflammation of paranasal sinuses. 
• It may be due to infection, allergies and immune disorder. 
• It may be due to exposure to cold air tobacco smoke, dust, acrid fumes. 
• It may get aggravated in emotional stress. 
• Many herbal and mineral preparations are available to treat sinusitis. 
• The trial drug is prepared at the P.G.Gunapadam lab of government siddha 
medical college and hospital, Palayamkottai, under the direct supervision of 
teaching faculties of P.G.Pothu Maruthuvam and Gunapadam. 
DETAILS OF THE TRIAL DRUG 
PERUNJCHIRAKA CHOORANAM 
DOSAGE: 2gm, two times after food 
DURATION: 30 days 
• Patients are advised to avoid betel chewing, tobacco and smoking. 
• Patients are advised to avoid exposure to allergens and cold climate. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
DEPARTMENT OF POTHU MARUTHUVAM 
 
PRECLINICAL AND  CLINICAL STUDY ON KABHAPEENISAM 
(SINUSITIS) WITH 
PERUNJCHIRAKA CHOORANAM 
 
 FORM VIII 
ADVERSE DRUG REACTION FORM 
 
Name: ________________________       OPD/ IPD No : __________ 
Age: ________               Sex: ___________ 
Date of trial commencement: ___________ 
Date of withdrawal from trial: ___________ 
Drug, dosage, route of administration: PERUNJCHIRAKA CHOORANAM 2gm 
(Internal) two times a day after food. 
Laboratory findings: 
______________________________________________________ 
Concomitant drug   : 
______________________________________________________ 
Description of adverse reaction: 
_____________________________________________ 
Management of adverse drug reaction : 
_______________________________________ 
Adjustment of dose of drug if any : 
__________________________________________ 
Patient outcome : 
_________________________________________________________ 
Date    : 
Station :        
Signature of Investigator                                                Signature of the HOD 
          
Signature of Reader/ Lecturer 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
DEPARTMENT OF   POTHU MARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON “KABHA PEENISAM ” 
(SINUSITIS) AND THE DRUG OF CHOICE IS PANCHAKOOLA                
KRITHAM ”(Internal). 
 
  FORM IX (DRUG COMPLIANCE FORM) VISIT I  
 
S. NO:________ OPD/ IPD NO:______________  REG  NO: 321211003/2014-15 
NAME:____________________________  AGE/SEX :______________________ 
Name of the drug : PERUNJCHIRAKA CHOORANAM (internal ). 
Drugs issued: (Nos)     Drugs issued:   (Nos) 
Drugs returned:(Nos)     Drugs returned:  (Nos)   
  
Date :                  
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                         
 
    Signature of the HOD 
DRUG TAKEN TIME 
S.NO DATE 
MORNING/TIME EVENING/TIME 
Day 1      
Day 2      
Day 3      
Day 4      
Day 5      
Day 6      
Day 7      
Day 8      
Day 9      
Day 10      
Day 11      
Day 12      
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL,                                      
PALAYAMKOTTAI 
DEPARTMENT OF   POTHUMARUTHUVAM 
PRE CLINICAL AND CLINICAL STUDY ON “KABHA PEENISAM” 
(SINUSITIS) AND THE DRUG OF CHOICE IS “PERUNJCHIRAKA 
CHOORANAM (internal). 
 
FORM IX (DRUG COMPLIANCE FORM) 
 
S. NO:_______ OPD/ IPD NO:_______________  REG  NO: 32121103/2014-15 
NAME:_________________________________ AGE___________________ 
Name of the drug : PERUNJCHIRAKA CHOORANAM(internal) . 
Drugs issued: (Nos)     Drugs issued:   (Nos) 
Drugs returned:(Nos)     Drugs returned:  (Nos)   
 
Date :                  
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                        Signature of the HOD 
DRUG TAKEN TIME DAYS                  DATE  
 MORNING/TIME EVENING/TIME 
Day 13      
Day 14      
Day 15      
Day 16      
Day 17      
Day 18      
Day 19      
Day 20      
Day 21      
Day 22      
Day 23      
Day 24      
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